Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Goosehead Insurance (GSHD - Free Report) , which belongs to the Zacks Insurance - Multi line industry.
This insurance company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 34.26%.
For the most recent quarter, Goosehead was expected to post earnings of $0.2 per share, but it reported $0.3 per share instead, representing a surprise of 50.00%. For the previous quarter, the consensus estimate was $0.54 per share, while it actually produced $0.64 per share, a surprise of 18.52%.
Price and EPS Surprise
Thanks in part to this history, there has been a favorable change in earnings estimates for Goosehead lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Goosehead currently has an Earnings ESP of +0.96%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on July 22, 2026.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
If you're searching for reliable income at a reasonable price, look no further than Portland General Electric (POR 0.21%). Shares of the Pacific Northwest utility business are currently trading in the low $50s, but the stock offers a strong dividend and steady growth. Even better, its valuation is quite reasonable at a time when many utilities and energy stocks are becoming more expensive.
Today's Change
(
-0.21
%) $
-0.11
Current Price
$
52.32
Portland General Electric's quarterly dividend currently pays $0.55 per share. This amounts to a yield that is slightly above 4%. That's higher than the broader market average and competitive within the utility sector. Meanwhile, the company's forward price-to-earnings (P/E) ratio of about 14 is below the sector average of roughly 23.
Image source: Getty Images.
Portland General Electric rewards shareholders with dividends, but the company also balances payouts with strategic capital reinvestments. The utility company is expanding its capabilities in Oregon and now into Washington state with its February acquisition of PacifiCorp's Washington-based utility operations.
The company has raised its dividends for more than a decade, and with artificial intelligence (AI)-related power demand as a catalyst, now is a good time for income investors to look at Portland General Electric. The company, which has a $6 billion market capitalization, pays dividends consistently but it also provides investors with a surprising amount of growth potential ahead.
Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
A Dividend King is a company that has increased its dividend for at least 50 years in a row. There are currently only 57 that can wear this crown.
One of them is Kimberly-Clark (KMB +0.06%), the venerable company that makes tissues, paper towels, diapers, and other paper-based family-care products. It has increased its dividend for 54 straight years, making its stock a Dividend King. But it also pays out one of the highest yields among Dividend Kings -- 4.7% right now. The combination makes it one of the best, most reliable dividend stocks you can buy.
But the stock is not just a buy for its royal dividend -- it's also positioned to deliver some solid returns. Here's why.
Image source: Getty Images.
A strategic shift toward higher-margin products Kimberly-Clark stock is up about 11% year to date (with dividends reinvested), but its total returns are down about 10% over the past 12 months. Its long-term returns aren't great either, as it averaged a drop of 1% over the past five years and a total rise of only 1% over the past decade.
Its main utility for investors has been to provide excellent dividend income, and some downside protection when markets go south. But some recent developments could position the company to generate some decent returns.
Earlier this month, Kimberly-Clark struck a deal with pulp supplier Suzano (SUZ +0.24%) to form a new paper products company, Arbex. This benefits Kimberly-Clark by offloading its lower-margin paper-towel and tissue business, allowing it to focus on its higher-margin personal-care products. Kimberly-Clark also has a licensing agreement with Arbex to license its paper brands, so that will generate some licensing royalties.
Today's Change
(
0.06
%) $
0.06
Current Price
$
108.41
A greater focus on absorbing its Kenvue acquisition More importantly, it frees up resources for Kimberly-Clark to integrate its pending acquisition of Kenvue (KVUE +0.16%).
Kenvue, which makes skincare products like Aveeno and consumer health products like Band-Aid, Tylenol, and Listerine (to name just a few), spun off from Johnson & Johnson in 2023. Kimberly-Clark sees it as a complementary fit, creating a global health and wellness leader, and expects the combination to maximize each company's strengths and accelerate growth.
Kimberly-Clark anticipates approximately $1.9 billion in cost synergies and roughly $500 million in profit from revenue synergies, within three to four years of the deal closing. It also expects to spend about $2.5 billion to realize these benefits in the first two years.
Long live the Dividend King Analysts are generally bullish on the acquisition, with several raising their price targets for the stock in recent weeks. They have a median price target of $113 per share, suggesting 5% upside. Shares are also cheap, trading at 14 times earnings.
I think Kimberly-Clark is a buy for its dividend alone. But investors may also see the added benefit of solid long-term returns following the major shift from this 154-year-old company.
New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Simply Good Foods Company ("Simply Good" or the "Company") (NASDAQ: SMPL).
CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION
If you are a Simply Good investor and have suffered losses, or if you have information that could assist in the Simply Good investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
On June 13, 2024, Simply Good announced the completion of the acquisition of Only What You Need (OWYN) for a purchase price of $280 million.
On October 23, 2025, Simply Good reported financial results for the fourth quarter of 2025, disclosing among other things, a "quality issue" with the Company's recently acquired OWYN brand, "related to a raw material sourcing decision for pea protein made prior to the closing of the acquisition."
Following this news, the price of Simply Good stock fell $4.33 per share, or 17.35%, to close at $20.63 per share on October 23, 2025
Then, on April 9, 2026, Simply Good reported financial results for the second quarter of 2026, including that "Net sales of $326.0 million decreased 9.4% versus the comparable year ago period, driven by declines for Atkins and OWYN of 26.6% and 16.8%, respectively." Simply Good also "recognized an aggregate $249.0 million non-cash, impairment charge related to the Atkins brand and OWYN brand intangible assets" comprised of "a loss on impairment $187.0 million for OWYN and $62.0 million for Atkins[.]"
Following this news, the price of Simply Good stock fell $2.61 per share, or 18.11%, to close at $11.80 per share on April 9, 2026.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this investigation, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Exelixis (EXEL - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis drug developer is expected to post quarterly earnings of $0.86 per share in its upcoming report, which represents a year-over-year change of +14.7%.
Revenues are expected to be $635 million, up 11.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Exelixis?For Exelixis, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +6.31%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that Exelixis will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Exelixis would post earnings of $0.75 per share when it actually produced earnings of $0.87, delivering a surprise of +16.00%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Exelixis appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsNovoCure (NVCR - Free Report) , another stock in the Zacks Medical - Biomedical and Genetics industry, is expected to report loss per share of $0.3 for the quarter ended June 2026. This estimate points to a year-over-year change of +16.7%. Revenues for the quarter are expected to be $174.11 million, up 9.6% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for NovoCure has been revised 1.5% up to the current level. Nevertheless, the company now has an Earnings ESP of +0.83%, reflecting a higher Most Accurate Estimate.
When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that NovoCure will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
#1 (Strong Buy) stocks have produced an unmatched +23.94% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Boise Cascade (BCC - Free Report) Boise Cascade Company is one of the largest wood products manufacturers and a leading United States wholesale distributor of building products, headquartered in Boise, ID. The company, which started its operations on Oct. 29, 2004, manufactures engineered wood products, plywood, lumber and particleboard and distributes wood products, such as decking, engineered wood products (EWP), lumber, panel, particleboard, and MDF products. Its main market operations are in the United States and Canada.
BCC is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B.
Momentum investors should take note of this Construction stock. BCC has a Momentum Style Score of B, and shares are up 3.4% over the past four weeks.
Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.16 to $3.83 per share. BCC boasts an average earnings surprise of +40.8%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, BCC should be on investors' short list.
Archer Aviation (NYSE:ACHR | ACHR Price Prediction) shares are trading higher in Monday morning action, up 14% to $5.06. The move follows a joint reveal by the company and privately held defense technology firm Anduril of an autonomous vertical takeoff and landing (VTOL) aircraft platform at the Farnborough Airshow.
The pop lands into a rough tape. Archer stock entered Monday down 41% year to date (YTD), part of a broader pre-revenue eVTOL de-rating that has hit the entire cohort of listed operators hard.
Peers Joby Aviation (NYSE:JOBY) and EHang Holdings (NASDAQ:EH) are quieter but still higher. Joby stock is up 2% to $7.41, while EHang stock is up 1% at $5.17. The news catalyst belongs to Archer alone, though.
Anduril Team-Up Unveils “Thunder” Autonomous VTOL Archer and Anduril presented a series hybrid-electric autonomous VTOL aircraft platform at Farnborough. Anduril debuted the defense variant, “Thunder,” a Group 5 autonomous attack rotorcraft designed to fly alongside crewed attack and assault aircraft. Group 5 is the Pentagon’s heaviest unmanned aircraft tier, the same weight class as major program-of-record platforms.
The dual-use design uses dual tiltrotors, offers runway-independent VTOL, and cruises efficiently on the wing. The teams have completed multiple full-scale surrogate test flights, with Thunder’s first flight targeted for 2027. Archer says it will announce its first commercial customers for the platform later this week.
Archer Aviation CEO Adam Goldstein called Thunder a clean-sheet, first-principles design. In prior commentary tied to the program, Goldstein asserted, “I believe our hybrid aircraft is the most sophisticated vertical lift platform ever developed. It is not incremental, it is generational.”
The autonomy stack behind the aircraft leans on NVIDIA (NASDAQ:NVDA) and Palantir Technologies (NASDAQ:PLTR). Archer has integrated NVIDIA’s IGX Thor platform for onboard compute and autonomy-ready flight systems, while Palantir was down-selected as a finalist for the FAA’s SMART AI project covering air traffic control modernization. Starlink LEO connectivity rounds out the connectivity layer for the Midnight air taxi.
Archer’s Q1 2026 report framed the setup. The company posted revenue of $1.6 million and a net loss of $217.7 million, versus a $93.4 million loss a year earlier, with liquidity near $1.8 billion. Goldstein described Archer as a “multi-threat company” targeting air taxi launch, phased government awards, and AI software deployments later this year.
Archer’s Peers Move Slightly on the News Joby Aviation and EHang have their own defense and autonomy narratives, but no fresh catalyst hit either name on Monday. Joby holds a defense partnership with L3Harris Technologies and recently flew a hybrid turbine-electric autonomous VTOL demonstrator, with first passenger service in Dubai still planned for later this year.
Joby stock is down 45% YTD and EHang stock is down 62% YTD. EHang delivered only four EH216 units in Q1 2026 versus 66 in Q4 2025. None of the three companies are profitable on a trailing basis, and none carry meaningful trailing P/E ratios.
That framing keeps this trio in venture-style bet territory, where each ticker reprices on idiosyncratic news rather than as a coordinated basket. On Monday, Archer is the only one with a headline, and the price action reflects this.
What to Watch Now The near-term marker for Archer is the first commercial customer announcements for the Thunder platform expected later this week. Traders may want to watch for whether those disclosures come with firm order economics or read closer to letters of intent.
Beyond that, Archer is advancing Phase 4 compliance testing under the FAA’s Type Certification process and targeting the start of U.S. commercial air taxi operations later in 2026. Archer has also been named Official Air Taxi Provider of the LA28 Olympic Games and selected in three winning eIPP applications covering eight states, adding a run of visible milestones into the next 18 months.
Today’s move matters because it broadens Archer’s story from a piloted air taxi bet into a dual-use defense platform play, with a credible defense prime attached. It doesn’t fix the cash burn or the pre-revenue reality, and Thunder’s first flight is still a 2027 event. Investors evaluating their exposure here can size their positions accordingly, keeping ACHR stock in a smaller, more speculative portion of a portfolio and watching for whether Monday’s gain holds into the close.
Electric air taxis could soon start packing some serious firepower.
Archer Aviation has teamed up with Anduril Industries, the military technology startup cofounded by Palmer Luckey, to create what the companies describe as a “Group 5 autonomous attack rotorcraft.”
The jointly developed aircraft, called “Thunder,” is a hybrid-electric vehicle “designed to multiply the combat power of current and next-generation crewed attack and assault aircraft,” the companies said Monday. The vehicle is intended for both defense and commercial use cases.
The initial list of commercial customers is expected to be announced by Archer later this week, with its first flight planned for next year.
Subscribe to the Daily newsletter.Fast Company's trending stories delivered to you every day
Thunder was announced at the Farnborough International Airshow in England, and effectively may allow Archer to tap into the defense market at a time when battlefield technology is rapidly evolving.
Shares of Archer Aviation (NYSE: ACHR) were up more than 10% on the news.
The commercial variant of Anduril and Archer’s jointly developed aircraft platform. [Image: Archer Aviation]“Clean sheet design”It’s the latest in a series of developments within the electric air taxi industry in recent years. Archer, for example, has made headlines by becoming the official air taxi provider for the 2028 Olympic Games in Los Angeles.
Archer Aviation CEO Adam Goldstein said the company is laser-focused on getting its air taxis certified and flying by the 2028 Olympics in Los Angeles.
"It's always been an ambitious goal," he told CNBC's Phil LeBeau on Monday at the Farnborough Air Show in the U.K. "It's still an ambitious goal, but we're certainly going to try our hardest to get there."
Archer on Monday unveiled its Thunder autonomous vertical takeoff and landing defense craft with Anduril, designed to accompany crewed aircraft and helicopters. The companies first joined forces in 2024.
Shares rallied more than 20%.
Archer is widely known for creating electric vertical takeoff and landing aircraft aimed at cutting emissions and traffic in crowded urban areas. However, the technology has faced a series of regulatory and infrastructure hurdles that have pushed back certification timelines.
In recent months, Archer and its peers have benefitted from President Donald Trump's latest eVTOL pilot program aimed at accelerating deployment, with testing across 26 states.
"This is really critical to gaining the trust of the public and the trust of the regulators that will ultimately lead to our certification," Goldstein told CNBC. "That step is going to be hugely critical in order to allow us to meet those timelines."
Read more CNBC tech newsElon Musk's Memphis AI empire is the epicenter of the data center backlashChinese startup Moonshot AI unveils Kimi model it says rivals OpenAI, AnthropicSpaceX stock falls after Starship test flight abortedMicrosoft's Nadella criticizes Anthropic's Fable for being 'editorially controlled'Archer and its peers have also steadily expanded their defense portfolios as the U.S. military invests in new technology on the battlefield and adds more artificial intelligence tools.
Goldstein called defense applications a "huge market" for Archer amid rising geopolitical tensions abroad. The aircraft also doesn't require the same certification process necessary for commercial use cases, he added.
"The applications we can bring in the defense world are quite impressive and very much needed for the warfighter," he said.
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.
While many investors like to look for momentum in stocks, this can be very tough to define. There is a lot of debate surrounding which metrics are the best to focus on and which are poor quality indicators of future performance. The Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.
Below, we take a look at Knight-Swift Transportation Holdings (KNX - Free Report) , a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.
It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Knight-Swift Transportation Holdings currently has a Zacks Rank of #1 (Strong Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of "A or B" outperform the market over the following one-month period.
You can see the current list of Zacks #1 Rank Stocks here >>>
Set to Beat the Market?Let's discuss some of the components of the Momentum Style Score for KNX that show why this trucking company shows promise as a solid momentum pick.
Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.
For KNX, shares are up 1.98% over the past week while the Zacks Transportation - Truck industry is up 2.92% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 3.41% compares favorably with the industry's 6.18% performance as well.
Considering longer term price metrics, like performance over the last three months or year, can be advantageous as well. Over the past quarter, shares of Knight-Swift Transportation Holdings have risen 17.61%, and are up 71.7% in the last year. On the other hand, the S&P 500 has only moved 4.96% and 19.65%, respectively.
Investors should also take note of KNX's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. Right now KNX is averaging 3,492,639 shares for the last 20 days..
Earnings OutlookThe Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock's price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with KNX.
Over the past two months, 4 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost KNX's consensus estimate, increasing from $1.94 to $2.04 in the past 60 days. Looking at the next fiscal year, 8 estimates have moved upwards while there have been no downward revisions in the same time period.
Bottom LineGiven these factors, it shouldn't be surprising that KNX is a #1 (Strong Buy) stock and boasts a Momentum Score of B. If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Knight-Swift Transportation Holdings on your short list.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: CBOE Global (CBOE - Free Report) Based in Chicago, IL, and founded in 1973, Cboe Global Markets, Inc. (effective Oct 17, 2017, CBOE Holdings, Inc. came to be known as Cboe Global Markets, Inc.) is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading.
CBOE is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Finance stock. CBOE has a Momentum Style Score of B, and shares are up 9.8% over the past four weeks.
Nine analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.47 to $13.56 per share. CBOE also boasts an average earnings surprise of +5.4%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CBOE should be on investors' short list.
Arm Holdings PLC (NASDAQ:ARM)'s long-term growth outlook is improving as rising demand for artificial intelligence workloads drives increased need for CPUs, according to Jefferies, which raised its price target on the semiconductor designer to $320 from $290.
The company’s shares are up almost 150% so far this year, trading hands at $272 on Monday afternoon.
Jefferies wrote that Arm’s AI-related CPU opportunity has expanded following the company’s fiscal 2026 results, driven by growing demand from agentic AI applications and new customer additions including Oracle and ByteDance. The firm now expects Arm’s AI CPU revenue to reach $18 billion in fiscal 2031, above the company’s guidance of $15 billion.
The analyst firm noted that the total addressable market for CPUs could reach $200 billion by 2030, up from an earlier estimate of more than $100 billion. Jefferies expects Arm’s AI CPUs to capture at least a 15% share of that market, with Meta projected to become the company’s largest customer, followed by OpenAI, Oracle and ByteDance.
Jefferies also raised its estimates for AI CPU revenue in fiscal 2028 and fiscal 2029, forecasting $1.5 billion and $3 billion, respectively, compared with previous estimates of $1.4 billion and $2.7 billion. The firm wrote that Arm could increase production capacity through higher-cost wafer supply options, which may weigh on gross margins but help the company secure market share.
The firm highlighted data centre as another area of potential growth, with royalty revenue expected to benefit from increasing adoption of Arm-based infrastructure. Jefferies noted that Arm’s compute subsystem-based royalties have increased to $1.50 per core from $1 previously.
Jefferies also pointed to a potential AI accelerator launch from SoftBank using Arm’s design services as a potential future royalty opportunity. The firm wrote that royalties from such products could exceed $7,000 per chip given the high average selling prices of GPUs, although volumes remain difficult to predict.
The firm expects Arm’s revenue and earnings to grow at more than 40% annually through fiscal 2031, with Jefferies forecasting a five-year earnings per share compound annual growth rate of 45%. Jefferies wrote that the company’s growth visibility and exposure to AI-driven CPU demand could support outperformance relative to the broader semiconductor sector.
The revised price target is based on a fiscal 2031 price-to-earnings multiple of 29 times, with Jefferies also citing discounted cash flow analysis as support for its valuation.
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/HELE.
Helen of Troy Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:
(1)Helen of Troy overstated the success and benefits of its Project Pegasus initiative, touting the “fuel” it was generating while downplaying issues such as “implementation hiccups” at its Tennessee distribution center and assuring investors that the project was progressing and delivering cost-saving efficiencies; (2)in reality, Project Pegasus was not delivering the efficiencies Defendants claimed, as the Company lacked sufficient resources and budget to achieve its stated restructuring and cost-savings goals; and (3)as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for Helen of Troy Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/HELE. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Helen of Troy you have until August 3, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Helen of Troy Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Helen of Troy Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFinding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to highlight the most attractive and discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +23.94% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Jones Lang LaSalle (JLL - Free Report) Chicago-based Jones Lang LaSalle Incorporated — popularly known as JLL — is a leading full-service real estate firm that provides corporate, financial and investment management services to corporations and other real estate owners, users and investors worldwide.
JLL is a #2 (Buy) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Finance stock. JLL has a Momentum Style Score of B, and shares are up 11.2% over the past four weeks.
Two analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.48 to $22.83 per share. JLL boasts an average earnings surprise of +12.1%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, JLL should be on investors' short list.
Jones Lang LaSalle (JLL - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Jones Lang LaSalle is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Jones Lang LaSalle imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Jones Lang LaSalleThis financial and professional services company is expected to earn $22.83 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for Jones Lang LaSalle. Over the past three months, the Zacks Consensus Estimate for the company has increased 4.9%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Jones Lang LaSalle to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Henry Schein (HSIC - Free Report) . This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat.
When looking at the last two reports, this health care products maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.54%, on average, in the last two quarters.
For the most recent quarter, Henry Schein was expected to post earnings of $1.2 per share, but it reported $1.32 per share instead, representing a surprise of 10.00%. For the previous quarter, the consensus estimate was $1.3 per share, while it actually produced $1.34 per share, a surprise of 3.08%.
Price and EPS Surprise
For Henry Schein, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.
Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Henry Schein has an Earnings ESP of +0.41% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #2 (Buy), it shows that another beat is possibly around the corner.
With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss.
Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate.
Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Space Exploration Technologies Corp (SPCX 1.05%), more commonly referred to as just SpaceX, is easily the most valuable space stock in the world, with a market cap of $1.6 trillion. Many investors are willing to look past its high valuation due to expectations of significant growth in the years ahead.
But what might surprise you is that in the next couple of years, there's a space stock that analysts expect will actually grow at a faster rate than SpaceX, and that's AST SpaceMobile (ASTS +0.97%).
Image source: Getty Images.
AST SpaceMobile is much smaller but growing at an extremely fast rate Last year, SpaceX reported nearly $19 billion in revenue, while AST SpaceMobile generated just under $71 million. Unlike SpaceX, which has a broad business focused on rockets, artificial intelligence (AI), and telecom, AST SpaceMobile is focused on creating a global space-based broadband network.
Its scope is much smaller, but its growth is expected to pick up significantly. According to LSEG data, analysts expect AST SpaceMobile's revenue to reach nearly $2 billion by 2028, up from $166 million this year, which translates into a compounded annual growth rate (CAGR) of around 246%. SpaceX, by comparison, is expected to average a CAGR of nearly 69% over the next couple of years, with its revenue projected to total more than $103 billion in 2028.
Today's Change
(
0.97
%) $
0.56
Current Price
$
58.36
Both stocks are expensive, risky buys AST SpaceMobile may be expected to rise at a far faster rate than SpaceX, but that doesn't necessarily make it a better buy. At a market cap of around $23 billion, investors are still paying a big premium for the business, as that valuation translates into a price-to-sales (P/S) multiple of nearly 190. SpaceX, by comparison, trades at about 80 times revenue. While neither stock is cheap, SpaceX is more attractively valued based on its revenue.
Today's Change
(
-1.05
%) $
-1.30
Current Price
$
122.69
The danger of investing in either one of these stocks is that they can be highly volatile and speculative, as their valuations depend more on future expectations than on what they have achieved thus far.
SpaceX has been struggling recently despite a strong rally out of the gate, and has now dipped below its IPO price. Shares of AST SpaceMobile are down about 20% thus far in 2026, as investors may be having second thoughts about its valuation. Both stocks, while they do have some promising upside, also have plenty of room to fall further. Investors should tread carefully with them.
Key Takeaways Nu Holdings reached 135 million customers as quarterly revenues and net income hit records.Mexico posted its first profitable quarter as Nu expanded to 15 million customers in four years.NU's credit portfolio rose 40%, while delinquencies increased and risk-adjusted margins declined. Nu Holdings Ltd. (NU - Free Report) , the parent of Nubank, has built one of Latin America’s largest digital financial platforms. Its branchless model combines credit cards, deposits, loans, payments and investment products in one mobile application. The company ended the first quarter of 2026 with more than 135 million customers across Brazil, Mexico and Colombia, giving it greater consumer reach than many digital-banking rivals.
NU shares have risen about 6.3% over the past month, outperforming close fintech peers SoFi Technologies, Inc. (SOFI - Free Report) and StoneCo Ltd. (STNE - Free Report) over a comparable recent period. SoFi and StoneCo shares have gained 1.1% and roughly 3.8%, respectively. The comparison suggests that investors have responded positively to Nu’s earnings growth, improving efficiency and progress in Mexico, even as the wider fintech group has remained uneven.
However, a rising share price does not remove the risks. NU is expanding lending rapidly, investing in artificial intelligence and preparing for measured entry into the United States. Investors must balance these growth opportunities against higher provisions, credit exposure and a valuation that already assumes continued execution.
Image Source: Zacks Investment Research
Customer Growth Supports the Bull Case for NUNu Holdings’ scale remains its clearest advantage. The company passed 115 million customers in Brazil, 15 million in Mexico and approached 5 million in Colombia. Monthly activity remained strong at 83%, while monthly average revenue per active customer increased to around $16. These trends helped quarterly revenues reach approximately $5 billion for the first time in the first quarter of 2026.
Profitability also improved. First-quarter net income reached a record $871 million, up 41% year over year on an FX-neutral basis. NU’s reported efficiency ratio fell to 17.6%, showing that revenues continue to grow faster than operating expenses. Management expects the full-year ratio to move closer to 20% as delayed marketing, property and investment costs return during later quarters.
Mexico offers another major opportunity. Nu Holdings’ customer base has expanded from slightly more than 2 million to 15 million in four years. The operation also recorded its first quarter of IFRS profitability ahead of management’s internal plan. Mexico remains underbanked, and NU currently controls less than 1% of the profit pool it hopes to address.
AI and New Products of NU Could Lift EngagementManagement is using artificial intelligence to speed product development, improve credit decisions and lower servicing costs. Engineering output increased more than 50% year over year, while AI-based financial tools were already serving above 15 million monthly active users. Nu Holdings’ proprietary models are being used for credit-card decisions and unsecured lending, allowing the company to assess individual loan requests in under one second.
The company is also expanding into small-business banking. NU has approximately 5 million small-business customers in Brazil, many acquired by cross-selling services to existing personal-banking users. This base could support further growth in business cards, deposits, and secured and unsecured loans without large customer-acquisition spending.
Credit Expansion Creates Risk for NUNU’s credit portfolio climbed 40% to $37.2 billion, led by a 53% increase in unsecured lending. Total credit exposure, including available card limits, rose 44% to $70.7 billion. Because credit cards and unsecured loans made up 98% of new exposure, the company had to record larger expected-loss provisions.
Early-stage delinquencies increased to 5% from 4.11% at year-end, while risk-adjusted net interest margin declined to 9.5% from 10.5%. Management attributed most of the change to normal seasonality, portfolio growth and product mix rather than weakening borrowers. Still, investors should closely watch these measures because rapid unsecured lending can produce larger losses during an economic downturn.
NU’s Estimate RevisionsWhile earnings estimates for both 2026 and 2027 have been revised marginally downward over the past 60 days, the consensus mark has remained unchanged in recent times. However, these figures suggest year-over-year growth of 33.87% and 38.07%, respectively.
Image Source: Zacks Investment Research
Is NU Stock Fairly Valued?NU trades at approximately 13.48 times forward earnings. That is well below SoFi Technologies’ forward multiple of about 24.53 times but considerably above StoneCo’s 4.9 times. The discount to SoFi appears reasonable because SoFi operates in the competitive U.S. market and receives a higher growth premium. Nu Holdings’ premium over StoneCo reflects its larger customer platform, stronger earnings expansion and broader consumer-banking opportunity.
NU's Valuation
Image Source: Zacks Investment Research
NU is not an obvious bargain. StoneCo offers a much cheaper valuation, while SoFi Technologies provides exposure to U.S. lending and financial technology. Investors choosing Nu Holdings over StoneCo or SoFi are betting that its Latin American scale, Mexico expansion and credit models will continue producing above-average growth.
NU Stock Recommendation: HoldNu Holdings has a strong long-term story built around customer growth, low operating costs and a rising presence beyond Brazil. Mexico’s first profitable quarter, higher customer revenues and record net income show that the business can scale effectively. AI tools and small-business products may create additional growth, while NU’s valuation is more reasonable than SoFi Technologies’ multiple.
However, the stock’s recent 6.3% rise, growing unsecured-credit exposure and higher provisions call for patience, and NU must ensure that rapid lending growth will not weaken asset quality. It seems prudent for existing investors to retain their positions, but new buyers may wait for a better entry price.
At present, NU carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways DPZ's Q2 EPS of $4.07 missed estimates, while revenues rose 4.3% YoY to $1.19B.DPZ's Q2 U.S. same-store sales rose 0.1% as supply chain revenues climbed to $731.7 million.Domino's added 209 stores, cut leverage to 4.3x and declared a $1.99 quarterly dividend. Domino's Pizza, Inc. (DPZ - Free Report) reported second-quarter fiscal 2026 results, with earnings missing the Zacks Consensus Estimate and revenues beating the same. The top and bottom lines increased on a year-over-year basis.
The company reported meaningful second-quarter order growth across both delivery and carryout channels despite persistent consumer demand pressures in the broader U.S. quick-service restaurant industry. Sustained order expansion remains a central component of Domino’s long-term growth framework, supported by new customer acquisition, greater loyalty program participation, increased supply chain throughput and continued store development. The company also cited its scale and competitive positioning as structural advantages that could support additional market-share gains and long-term shareholder value creation.
DPZ's Q2 Earnings & RevenuesDomino's reported second-quarter 2026 earnings of $4.07 per share, missing the Zacks Consensus Estimate of $4.11 by 1%. However, the bottom line increased 6.8% from $3.81 reported in the year-ago quarter.
Quarterly revenues of $1.19 billion surpassed the consensus estimate of $1.17 billion by 2.1% and rose 4.3% year over year. Higher supply chain revenues, franchise royalties and advertising revenues supported growth, while U.S. same-store sales increased 0.1% year over year.
DPZ's Q2 Supply Chain Business Drives Revenue GrowthSupply chain revenues increased to $731.7 million from $687.1 million reported in the prior-year quarter. The improvement reflected higher-order volumes and a 2.2% increase in food basket pricing. Our estimate for the metric was $749.9 million.
In the second quarter, U.S. franchise royalties and fees rose to $164.2 million compared with $156.3 million reported in the prior-year quarter. Our estimate for the metric was $140.7 million.
International franchise royalties and fees advanced to $81.8 million from $77.2 million, supported by net store growth and a $1.1 million favorable foreign currency impact. Our estimate for the metric was $82.8 million.
U.S. franchise advertising revenues increased to $134.9 million from $132.2 million. Our estimate for the metric was $119.1 million.
Domino's Q2 Comparable Sales Show Uneven DemandGlobal retail sales increased 3% year over year, excluding foreign currency movements. U.S. retail sales rose 1.9%, while international retail sales increased 4.1% on a constant-currency basis.
Comparable sales trends were more subdued. U.S. same-store sales edged up 0.1% compared with 3.4% growth a year earlier. Company-owned store comps increased 2.1% year over year, while franchise store comps were flat. International same-store sales declined 0.1% against a 2.4% increase reported in the prior-year quarter.
Domino's Q2 Margin Performance Remains MixedIn the second quarter, Gross margin dollars came in at $478.2 million compared with $461 million reported in the prior-year quarter. However, gross margin as a percentage of revenues contracted 30 basis points year over year to 40%. Our estimate for the metric was 39%.
Supply chain gross margin expanded 20 basis points year over year to 12%, aided by procurement productivity. The benefit was partly offset by higher food basket costs. General and administrative expenses came in at $115.4 million compared with $107.6 million reported in the prior-year quarter.
DPZ Posts Higher Operating Income and Net ProfitIn the second quarter, income from operations increased 3.1% year over year to $232 million. Excluding the favorable currency impact on international franchise royalties, operating income rose 2.6%, driven by franchise royalty growth and higher supply chain gross profit. Our estimate for the metric was $242.1 million.
Net income advanced 3.6% year over year to $135.8 million. Results also benefited from a favorable $3.6 million change in pre-tax unrealized and realized losses tied to the company’s investment in DPC Dash.
DPZ Extends Its Global Store ExpansionDomino’s posted global net store growth of 209 during the quarter. The company added 26 net stores in the United States and 183 internationally, bringing its worldwide store count to 22,531.
The U.S. system ended the period with 7,231 locations, while the international network reached 15,300 stores. Over the trailing four quarters, net store growth totaled 995, including 170 domestic and 825 international additions.
Domino's Cash Flow Moderates in the First HalfNet cash provided by operating activities totaled $352.6 million during the first two quarters of 2026, down from $366.9 million in the comparable 2025 period. Capital expenditures increased to $39 million from $35.2 million reported in the prior-year period.
Free cash flow declined 5.5% year over year to $313.6 million. The decrease reflected changes in operating assets and liabilities, along with the timing and amount of advertising-related payments. Cash and cash equivalents stood at $164.8 million as of June 14, 2026.
DPZ Returns Capital While Lowering LeverageDomino’s repurchased 443,917 shares for $156.2 million during the quarter. The company had $1.23 billion remaining under its share repurchase authorization at quarter-end.
The leverage ratio improved to 4.3 times from 4.7 times a year earlier. Following the quarter, the board declared a quarterly dividend of $1.99 per share, payable Sept. 30, 2026, to its shareholders of record as of Sept. 15.
DPZ’s Zacks RankDomino's currently has a Zacks Rank #4 (Sell).
Stocks to ConsiderHere are some better-ranked stocks from the Zacks Retail-Wholesale sector:
Five Below, Inc. (FIVE - Free Report) presently sports a Zacks Rank #1 (Strong Buy). The company delivered a trailing four-quarter earnings surprise of 70.1%, on average. FIVE stock has gained 3.4% in the past six months. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Five Below’s 2026 sales and EPS indicates growth of 14.8% and 35.1%, respectively, from the year-ago period’s levels.
FIGS, Inc. (FIGS - Free Report) has a Zacks Rank #2 (Buy) at present. The company delivered a trailing four-quarter earnings surprise of 212.5%, on average. FIGS stock has declined 11% in the past six months.
The Zacks Consensus Estimate for FIGS’ 2026 sales and EPS indicates growth of 15.5% and 36.8%, respectively, from the prior-year levels.
Dutch Bros Inc. (BROS - Free Report) carries a Zacks Rank of 2 at present. The company delivered a trailing four-quarter earnings surprise of 31.6%, on average. BROS stock has increased 11.7% in the past six months.
The Zacks Consensus Estimate for Dutch Bros’ 2026 sales and EPS indicates growth of 26.9% and 22.4%, respectively, from the prior-year levels.
On this episode of Stock Movers: - AMC Entertainment (AMC) shares jumped after it reported strong adjusted Ebitda for the second quarter that beat the average analyst estimate. - Domino's Pizza Group (DPZ) is moving following news its US comparable sales growth fell to its slowest pace in five quarters, suggesting consumers continue to pull back on dining out, with pizza faring worse than burgers or burrito bowls.
Domino's Pizza (DPZ - Free Report) came out with quarterly earnings of $4.07 per share, missing the Zacks Consensus Estimate of $4.11 per share. This compares to earnings of $3.81 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -0.97%. A quarter ago, it was expected that this pizza chain would post earnings of $4.29 per share when it actually produced earnings of $4.13, delivering a surprise of -3.73%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.
Domino's Pizza, which belongs to the Zacks Retail - Restaurants industry, posted revenues of $1.19 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.07%. This compares to year-ago revenues of $1.15 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Domino's Pizza shares have lost about 22.7% since the beginning of the year versus the S&P 500's gain of 8.9%.
What's Next for Domino's Pizza?While Domino's Pizza has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Domino's Pizza was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $4.31 on $1.2 billion in revenues for the coming quarter and $18.88 on $5.16 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Retail - Restaurants is currently in the bottom 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Cheesecake Factory (CAKE - Free Report) , is yet to report results for the quarter ended June 2026. The results are expected to be released on July 28.
This restaurant chain is expected to post quarterly earnings of $1.16 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level.
Cheesecake Factory's revenues are expected to be $996.23 million, up 4.2% from the year-ago quarter.
Domino's Pizza (DPZ - Free Report) reported $1.19 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 4.3%. EPS of $4.07 for the same period compares to $3.81 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.17 billion, representing a surprise of +2.07%. The company delivered an EPS surprise of -0.97%, with the consensus EPS estimate being $4.11.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Domino's Pizza performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Store counts - Opened - Total: 250 versus the five-analyst average estimate of 244.Store counts - U.S. Company-owned Stores: 186 versus 263 estimated by five analysts on average.Store counts - U.S. Franchise Stores: 7,045 versus 6,976 estimated by five analysts on average.Store counts - International Stores: 15,300 compared to the 15,281 average estimate based on five analysts.Store counts - Total: 22,531 versus the five-analyst average estimate of 22,520.Same store sales growth - U.S. stores: 0.1% versus the five-analyst average estimate of -0.3%.Store counts - Total U.S. Stores: 7,231 versus 7,239 estimated by five analysts on average.Revenues- U.S. franchise advertising: $134.9 million versus the six-analyst average estimate of $132.66 million. The reported number represents a year-over-year change of +2%.Revenues- U.S. Company-owned stores: $81.83 million compared to the $87.2 million average estimate based on six analysts. The reported number represents a change of -11.5% year over year.Revenues- Supply chain: $731.71 million versus the six-analyst average estimate of $718.84 million. The reported number represents a year-over-year change of +6.5%.Revenues- International franchise royalties and fees: $81.82 million versus the six-analyst average estimate of $82.28 million. The reported number represents a year-over-year change of +6%.Revenues- U.S. franchise royalties and fees: $164.17 million compared to the $157.1 million average estimate based on six analysts. The reported number represents a change of +5.1% year over year.View all Key Company Metrics for Domino's Pizza here>>>
Shares of Domino's Pizza have returned +3.1% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term InvestorsDomino's Pizza NASDAQ: DPZ executives said second-quarter U.S. demand remained strong in terms of order counts, but a weaker-than-expected ticket dragged on same-store sales as the company lapped last year’s Stuffed Crust Pizza launch.
On the company’s rescheduled second-quarter 2026 earnings call, Chief Executive Officer Russell Weiner said the company grew order counts “meaningfully” across both delivery and carryout, even as the broader quick-service restaurant industry faced pressure from macroeconomic uncertainty and heightened competition. However, he said same-store sales fell short of expectations because the company’s premium series and Slice Sauce promotion did not resonate with customers enough to offset the prior-year benefit from Stuffed Crust.
Get Domino's Pizza alerts:
MarketBeat Week in Review – 06/22 - 06/26“The miss on ticket was largely within our control, which means we can and will address it moving forward,” Weiner said.
Leadership Transition Announced The call also featured comments from Joe Jordan, Domino’s incoming CEO. Weiner said the board unanimously elected Jordan, who has spent 15 years with the company and most recently served as chief operating officer. Jordan is expected to become CEO in October, while Weiner said he will transition to executive chairman next year.
Domino's Stock Slides to 52-Week Low as Investors Digest CEO ChangeJordan said Domino’s priorities remain focused on serving customers with food, value and experience, supporting franchisees and executing with discipline to drive long-term growth.
“We have an exceptional global franchise system, talented people, a culture of innovation and operational excellence, and a brand that continues to earn the trust of customers every day,” Jordan said.
Second-Quarter Sales Lifted by Store Growth, Pressured by Ticket Chief Financial Officer Sandeep Reddy said income from operations increased 2.6% in the second quarter, excluding foreign currency impacts and refranchising gains from the sale of certain U.S. company-owned store markets in the second quarters of 2026 and 2025. The increase was driven primarily by higher U.S. and international franchise royalties and fees, along with supply chain gross margin dollar growth tied to U.S. order count growth. Those gains were partially offset by higher general and administrative expenses related to the company’s biennial worldwide rally.
Global retail sales rose 3% excluding foreign currency, supported by nearly 1,000 net new stores over the past 12 months. U.S. retail sales increased 1.9%, driven primarily by net store growth, including 26 net new U.S. stores during the quarter. U.S. same-store sales rose 0.1%, with carryout comps up 1.1% and delivery comps down 0.7%. Pricing was up 0.2%.
Reddy said the U.S. comp reflected strong order count growth in the core business and continued growth through aggregator channels, offset by lower average ticket. The company said it believes QSR industry order counts were flat during the quarter, while Domino’s grew orders in total and separately in delivery and carryout.
Weiner said the company’s order count growth is central to its strategy because orders bring customers into its loyalty program and support the company’s supply chain business. He said Domino’s has more than doubled U.S. system orders since he joined the company at the end of 2008, contributing to market share gains, additional retail sales, net new stores and higher franchisee store-level EBITDA.
Aggregator Business and Product Innovation in Focus Executives highlighted continued growth on third-party delivery platforms. Weiner said Domino’s believes it is now the No. 1 pizza company on both Uber and DoorDash, while still seeing “a significant amount of growth ahead” to reach what it views as fair share on those platforms.
In response to an analyst question, Weiner said Domino’s prices at a premium on aggregators and aims to be profit neutral for franchisees. Reddy added that the company is being deliberate in pursuing aggregator growth to protect profitability, calling the channel “one more lever” to drive franchisee profitability.
Weiner also discussed the company’s “orchestration agent,” a back-of-house technology designed to time pizza production so orders are hotter when handed to delivery drivers or customers. He said the system applies to orders placed through Domino’s own channels as well as aggregators.
Domino’s is also preparing to launch a new pizza product later in the third quarter. Weiner said the product is intended to address an unmet consumer need and hit an occasion that the pizza category does not serve well today. He described it as “unlike anything we’ve offered before at Domino’s” and said customer testing showed it was one of the best-tasting products the company has tested.
The company has already changed its third-quarter promotional calendar, including adding Stuffed Crust to its Best Deal Ever promotion. Weiner said customer reaction indicated the change was the right move.
International Results Mixed International retail sales grew 4.1% excluding foreign currency, primarily due to net store growth over the past year, including 183 net new international stores in the quarter. International same-store sales declined 0.1%.
Reddy said international comps continued to be affected by Domino’s Pizza Enterprises, which remains focused on turning around its business, as well as macroeconomic and geopolitical uncertainty across global markets. Weiner said Domino’s is looking forward to working with Andrew Gregory, the incoming CEO of Domino’s Pizza Enterprises, and noted that China and India have continued to be standouts over time.
Guidance and Capital Allocation Domino’s maintained its expectation for U.S. same-store sales to increase in the low single digits for 2026, excluding the impact of a 53rd week. The company also continues to expect international same-store sales growth in the low single digits, including the benefit of the recently concluded World Cup soccer tournament.
The company adjusted its U.S. net store outlook to approximately 175 stores from its prior expectation of 175-plus, citing some pressure on the pipeline from macro conditions and a challenging start to the year that affected franchisee profitability. Domino’s continues to expect approximately 800 net new international stores and mid-single-digit global retail sales growth for the year.
Domino’s also maintained its expectation for mid- to high-single-digit operating income growth, excluding foreign currency, refranchising gains and the gain on the sale of its corporate aircraft.
Through the second quarter, Domino’s repurchased about 632,000 shares for $231 million year to date. Reddy said the company had approximately $1.23 billion remaining on its share repurchase authorization at quarter end and continues to expect to return meaningful cash to shareholders in 2026 and beyond.
About Domino's Pizza (NASDAQ:DPZ)Domino’s Pizza, Inc NASDAQ: DPZ is a global pizza delivery and carryout chain founded in 1960 and headquartered in Ann Arbor, Michigan. The company specializes in a broad range of hand‐crafted pizzas, including hand-tossed, thin crust and specialty offerings, alongside side items such as chicken wings, sandwiches, pasta, desserts and beverages. Domino’s has built its brand on convenience and speed, leveraging proprietary ordering platforms and its Domino’s Tracker system to provide real-time status updates from order placement through delivery.
Operating predominantly under a franchise model, Domino’s has more than 17,000 stores worldwide, with approximately 95% of outlets owned and operated by independent franchisees.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Domino's Pizza Right Now?Before you consider Domino's Pizza, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Domino's Pizza wasn't on the list.
While Domino's Pizza currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Sweetgreen (SG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
U.S. regulators walked back its findings about contaminated lettuce, saying that the Taylor Farms sample initially reported as positive for cyclospora was actually a false positive.
New York, New York--(Newsfile Corp. - July 20, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Fulcrum Therapeutics, Inc. ("Fulcrum Therapeutics" or the "Company") (NASDAQ: FULC).
CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION
If you are a Fulcrum Therapeutics investor and have suffered losses, or if you have information that could assist in the Fulcrum Therapeutics investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) 329-8571.
Fulcrum Therapeutics is a "clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with rare hematological disorders[.]"
On June 1, 2026, after market close, Fulcrum Therapeutics announced in a press release "the discontinuation of its pociredir program for the treatment of SCD [(sickle cell disease).]" The Company stated that the "meeting minutes from recent end-of-phase interactions with the [U.S. Food and Drug Administration ("FDA")]" "reflected heightened FDA concerns regarding pociredir's benefit-risk profile in SCD, stemming from an unexpectedly high rate of secondary hematologic malignancies observed with Tazverik® (tazemetostat), another PRC2 inhibitor, which was withdrawn from the global market in March 2026." After submitting further information, the FDA "concluded that any pharmacological intervention targeting the PRC2 complex carries equivalent malignancy risk regardless of the specific subunit engaged." As a result, the Company has "no viable regulatory path forward for further clinical development of pociredir."
Following this news, the price of Fulcrum Therapeutics stock declined from a closing price on June 1, 2026 of $6.42 per share to close at $3.14 per share on June 2, 2026, a decline of $3.28 per share, or by 51.09%.
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America-the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act-$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
If you have any questions about this investigation, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
Key Takeaways NVR is expected to post lower earnings and revenues amid a softer housing market.NVR's homebuilding business is likely to have faced pressure as affordability challenges curb buyer demand.NVR is expected to see modest improvement in orders and backlog despite settlement and margin pressure. NVR, Inc. (NVR - Free Report) is expected to report lower earnings in the second quarter of 2026. Homebuilding revenues are also likely to have decreased on a year-over-year basis, given soft demand and margin headwinds.
In the last reported quarter, earnings and homebuilding revenues missed the Zacks Consensus Estimate by 13.4% and 7.9%, respectively. Also, both metrics declined on a year-over-year basis by 29% and 22%.
The company’s earnings beat the consensus mark in three of the last four quarters and missed once, the average surprise being 2.5%.
How Are Estimates Placed for NVR Stock?The Zacks Consensus Estimate for the to-be-reported quarter’s EPS has increased to $95.80 from $95.20 in the past 30 days. The estimated figure indicates a 11.74% decrease from the year-ago EPS of $108.54.
The consensus mark for revenues is pegged at $2.41 billion, indicating a decrease of 5.6% from the year-ago reported figure of $2.55 billion.
Factors Likely to Shape NVR’s Q2 ResultsNVR's second-quarter Homebuilding revenues are expected to have remained under pressure as elevated mortgage rates and higher homeownership costs are likely to have continued to limit affordability across many markets. Affordability challenges, coupled with cautious consumer sentiment, are expected to have delayed purchase decisions and moderated buyer demand during the quarter. The company is also likely to have maintained elevated sales incentives to support demand amid the challenging housing environment.
Our model predicts Homebuilding revenues (which accounted for 97.8% of total revenues in 2025) to decline 5.5% year over year to $2.41 billion in the to-be-reported quarter. For the quarter to be reported, we anticipate total settlements to decrease 6.7% to 5,107 units on a year-over-year basis.
The company's bottom line is expected to have decreased year over year in the quarter as elevated sales incentives are likely to have weighed on profitability. At the same time, higher lot, labor and building materials costs are expected to have increased construction expenses, creating additional pressure on homebuilding margins. We expect the homebuilding gross margin to be 18.3%, down 320 basis points year over year.
Our model predicts total new orders to increase slightly by 0.8% year over year to 5,421 units. The backlog is currently pegged at 10,484 units, which indicates an increase from 10,069 units reported a year ago. We expect the value of the backlog to be $4.77 billion, implying a slight increase from $4.75 billion in the corresponding year-ago quarter.
What the Zacks Model Unveils for NVROur proven model does not conclusively predict an earnings beat for NVR for the quarter to be reported. The company does not have the right combination of the two key ingredients — a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) — to increase the odds of an earnings beat.
NVR’s Earnings ESP: The company has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
NVR’s Zacks Rank: NVR currently carries a Zacks Rank #3 (Hold).
Stocks With the Favorable CombinationHere are some companies in the Zacks Construction sector that, according to our model, have the right combination of elements to post an earnings beat in the quarter to be reported.
Dycom Industries, Inc. (DY - Free Report) currently has an Earnings ESP of +0.47% and sports a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.
With the average surprise being 25%, Dycom’s earnings beat estimates in the last four quarters. Dycom’s earnings for the to-be-reported quarter are expected to increase 39.3%.
Owens Corning (OC - Free Report) has an Earnings ESP of +1.66% and a Zacks Rank of 3 at present.
For the quarter to be reported, Owens Corning’s earnings are expected to decline 27.3%. OC’s earnings beat estimates in three of the last four quarters and missed on one occasion, the average surprise being 3.8%.
United Rentals (URI - Free Report) currently has an Earnings ESP of +1.39% and a Zacks Rank of 2.
The company’s earnings beat estimates in one of the trailing four quarters and missed on the other three occasions, the average negative surprise being 1.5%. United Rentals’ earnings for the quarter are expected to increase 11.5%.
Key Takeaways TTMI is benefiting from AI-driven demand for advanced PCBs, RF components and a growing backlog.UCTT is expanding with semiconductor equipment demand, advanced packaging and manufacturing solutions.UCTT trades at a lower forward earnings multiple than TTMI, offering a more attractive valuation. TTM Technologies (TTMI - Free Report) and Ultra Clean Holdings (UCTT - Free Report) are key suppliers to the semiconductor manufacturing ecosystem and are benefiting from the rapid buildout of AI infrastructure. TTMI provides advanced printed circuit boards (PCBs) and RF components used in AI, networking and semiconductor applications, while UCTT supplies critical subsystems and ultra-high-purity manufacturing solutions that enable semiconductor equipment manufacturing.
Both companies are benefiting from rising semiconductor capital spending, driven by growing investment in AI data centers, advanced packaging and next-generation chip manufacturing. As AI infrastructure spending continues to accelerate, both stocks are well-positioned to capitalize on this secular growth trend. Let's delve deep to determine which one is a better investment now.
The Case for TTMITTM Technologies has established itself as a leading supplier of advanced PCBs, RF components and engineered interconnect solutions that support semiconductor manufacturing and AI infrastructure. As semiconductor devices grow more complex, demand has been driven by high-layer-count PCBs that enable advanced processors, accelerators and networking equipment used in AI data centers. TTMI has expanded its capabilities across advanced packaging, substrates and integrated modules, moving it higher up the electronics value chain while strengthening its position within the semiconductor supply chain. Its diversified global manufacturing footprint has enhanced supply chain flexibility, while its presence in aerospace and defense adds a stable, high-value demand source.
TTMI's growth has been supported by rising AI infrastructure investment across data center and networking applications, where higher-performance interconnect solutions have become critical. Forward demand visibility is reinforced by a book-to-bill ratio of 1.41 in the first quarter of 2026, with the commercial segment at 1.65, alongside a 90-day backlog of $787 million, up from $517 million a year earlier. Revenues rose 30% year over year to $846 million in the first quarter, driven by a 61% increase in data center and networking revenues, while aerospace and defense revenues grew 11%. Adjusted EBITDA margin expanded 40 basis points to 15.7% on a favorable mix and operating leverage.
The Zacks Consensus Estimate for TTMI's 2026 EPS is pegged at $4.13, down by 4 cents over the past 30 days, indicating 67.9% year-over-year growth, reflecting expectations of sustained earnings expansion as semiconductor capital spending and AI infrastructure investment continue.
The Case for UCTTUltra Clean Holdings has built its business around critical subsystems, ultra-high purity manufacturing solutions and outsourced services that enable advanced semiconductor manufacturing, positioning it at the center of wafer fabrication equipment expansion. As AI-driven computing increases demand for advanced logic, high bandwidth memory and advanced packaging, UCTT has benefited from rising investment in semiconductor fabrication equipment. Its UCT 3.0 strategy, centered on ramp readiness, new product introduction and digital transformation, has strengthened manufacturing efficiency while enabling customers to accelerate production ramps. A scalable global manufacturing footprint has further enhanced the company's ability to support growing customer demand with limited incremental capital investment.
Higher process complexity and rising equipment intensity in deposition, etch, and advanced packaging have continued to expand UCTT's addressable market, while growing wafer starts have supported its services business. These trends have already begun translating into stronger financial performance. First-quarter 2026 revenues increased to $533.7 million, gross margin expanded 40 basis points sequentially to 16.5%, and EPS improved 7 cents sequentially to 31 cents. Second-quarter guidance pointed to further revenue and earnings growth, reflecting continued momentum across the semiconductor equipment market.
The Zacks Consensus Estimate for UCTT's 2026 EPS is pegged at $2.46 per share, unchanged over the past 30 days, suggesting 134.3% year-over-year growth as AI-driven semiconductor investments and WFE spending continue to support earnings expansion.
Price Performance and Valuation of TTMI & UCTTWhile both stocks have been exceptional year-to-date (YTD) performers, UCTT's 264.9% return has outpaced TTMI's 91.3% appreciation, reflecting Ultra Clean's sharper earnings growth trajectory tied to the WFE upcycle.
TTMI vs UCTT: YTD Performance
Image Source: Zacks Investment Research
UCTT offers a more attractive valuation, trading at 24.27X forward 12-month earnings versus 27.04X for TTMI. The lower multiple, combined with stronger earnings growth expectations, points to a more favorable risk-reward setup for UCTT.
TTMI vs UCTT: Valuation
Image Source: Zacks Investment Research
ConclusionBoth TTM Technologies and Ultra Clean Holdings remain well-positioned to benefit from accelerating AI infrastructure investment and rising semiconductor capital spending. TTMI continues to capitalize on strong demand for advanced interconnect solutions, supported by expanding AI networking deployments and a growing backlog. However, UCTT stands out with stronger projected earnings growth, superior year-to-date share price performance and a more attractive valuation.
UCTT currently sports a Zacks Rank #1 (Strong Buy), while TTMI has a Zacks Rank #2 (Buy). Given its favorable growth outlook and valuation, UCTT appears to be a smarter investment over TTMI at current levels. You can see the complete list of today's Zacks #1 Rank stocks here.
Tempus AI (NASDAQ:TEM) will acquire Personalis (NASDAQ:PNSL) in a stock deal valued at $1.5 billion, expanding its reach in the market for tests that monitor cancer recurrence after treatment.
Personalis shareholders will receive $16.25 per share, a 6% premium to Friday's closing price and a 28% premium to the unaffected 30-day volume-weighted average price.
The deal is structured as an all-stock transaction, though Tempus has the option to pay up to 50% of the consideration in cash, with a maximum exchange ratio of 0.3356 Tempus shares for each Personalis share.
Shares of Tempus fell more than 8% Monday, while Personalis dropped 11.5%.
The acquisition builds on a partnership the companies established in November 2023, when Tempus invested in Personalis and began commercializing its NeXT Personal minimal residual disease (MRD) test.
Personalis' technology, which tracks circulating tumor DNA to detect cancer recurrence and monitor treatment response, has Medicare coverage in three indications.
"MRD is a large and rapidly growing market with the potential to truly transform how cancer patients are monitored, helping clinicians make faster and more informed decisions when cancer recurs," said Eric Lefkofsky, CEO of Tempus.
Personalis reported preliminary second-quarter revenue of $22.4 million, with 10,384 clinical tests delivered in the quarter, a 33% increase in volumes from the prior quarter.
The deal, approved by both companies' boards, is expected to close in late 2026 or early 2027, pending Personalis shareholder approval and regulatory clearance.
Tempus AI (NASDAQ:TEM) will acquire Personalis (NASDAQ:PNSL) in a stock deal valued at $1.5 billion, expanding its reach in the market for tests that monitor cancer recurrence after treatment.
Personalis shareholders will receive $16.25 per share, a 6% premium to Friday's closing price and a 28% premium to the unaffected 30-day volume-weighted average price.
The deal is structured as an all-stock transaction, though Tempus has the option to pay up to 50% of the consideration in cash, with a maximum exchange ratio of 0.3356 Tempus shares for each Personalis share.
Shares of Tempus fell more than 8% Monday, while Personalis dropped 11.5%.
The acquisition builds on a partnership the companies established in November 2023, when Tempus invested in Personalis and began commercializing its NeXT Personal minimal residual disease (MRD) test.
Personalis' technology, which tracks circulating tumor DNA to detect cancer recurrence and monitor treatment response, has Medicare coverage in three indications.
"MRD is a large and rapidly growing market with the potential to truly transform how cancer patients are monitored, helping clinicians make faster and more informed decisions when cancer recurs," said Eric Lefkofsky, CEO of Tempus.
Personalis reported preliminary second-quarter revenue of $22.4 million, with 10,384 clinical tests delivered in the quarter, a 33% increase in volumes from the prior quarter.
The deal, approved by both companies' boards, is expected to close in late 2026 or early 2027, pending Personalis shareholder approval and regulatory clearance.
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD LiveCustomer Center
My Stock Lists
Email Preferences
Help & Support
Sign Out
Search stocks or keywords
Sections
My IBD
MARKET TREND
STOCK LISTS
STOCK RESEARCH
NEWSECONOMY
VIDEOS & PODCASTS
HOW TO INVESTEDUCATIONAL RESOURCESStoreMy Products
Founder's ClubSwingTraderLeaderboardMarketSurgeeIBDIBD DigitalIBD Live
Recently Searched
Stock Market Week Ahead: Navigating Uncertainty
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Google Holds Top Rating
ASML, Snowflake Lead Five Stocks Near Buy Points In Tough Market Tempus AI (TEM) pledged to buy cancer diagnostics outfit Personalis (PSNL) for $1.5 billion on Monday. But shares of both medtech companies skidded. The deal follows a rumor last week that Merck (MRK) and others, including potentially Tempus AI, had expressed interest in buying Personalis. Personalis makes a blood test called NeXT Personal that screens for circulating tumor DNA, a…
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a nationally recognized shareholder rights firm, is investigating the proposed acquisition of Personalis, Inc. (Nasdaq: PSNL) by Tempus AI, Inc. (Nasdaq: TEM), an existing Personalis shareholder and strategic partner.
For a free consultation, please visit https://julieholleman.com/personalis-inc/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at [email protected].
Personalis is a precision oncology company that develops advanced genomic tests designed to detect and monitor cancer. The company has established itself as a leader in molecular residual disease ("MRD") testing, a rapidly growing market with significant long-term potential.
On July 20, 2026, Personalis announced that it had agreed to be acquired by Tempus for consideration valued at $16.25 per share. Tempus, however, is not a typical third-party acquirer. The company already owns a significant equity stake in Personalis through an existing strategic relationship that began in 2023 and has worked closely with Personalis in commercializing its MRD technology.
Julie & Holleman is investigating whether Personalis' public shareholders are receiving fair value for their shares. The firm is particularly concerned that Tempus' preexisting ownership position and strategic relationship with Personalis may have created conflicts of interest during the sale process. The firm is also evaluating whether the merger consideration adequately reflects Personalis' long-term value as demand for MRD testing continues to grow.
FIRM INFORMATION
Julie & Holleman is a boutique law firm that focuses on shareholder litigation, including derivative actions, mergers and acquisitions cases, securities fraud class actions, and corporate investigations. The firm’s attorneys litigate in state and federal courts across the nation and have helped secure hundreds of millions of dollars for aggrieved companies and their shareholders. For more information about the firm, please visit www.julieholleman.com. This notice may constitute attorney advertising.
Julie & Holleman LLP
W. Scott Holleman, Esq.
157 East 86th Street
4th Floor
New York, NY 10028
(929) 415-1020
www.julieholleman.com
MarketBeat Week in Review – 02/23 - 02/27Tempus AI NASDAQ: TEM executives said the company’s planned acquisition of Personalis is intended to strengthen its position in minimal residual disease, or MRD, testing, while expanding its biopharma data and profiling capabilities.
On a call with analysts, Tempus said it agreed to acquire all outstanding shares of Personalis not already owned by Tempus at $16.25 per share. The company said the price represents a 6% premium to Personalis’ Friday closing price and a 28% premium to its unaffected 30-day volume-weighted average price.
Get Tempus AI alerts:
After a Near 50% Drop, Tempus AI Could Be Ripe for a ReboundThe consideration is structured as 100% stock, though Tempus has the option to pay up to 50% in cash. Personalis shareholders would receive a floating exchange ratio of Tempus common stock for each Personalis share held at closing, subject to a maximum exchange ratio of 0.3356. Tempus said any cash portion could be financed with cash on hand and additional borrowing procured between signing and closing. The companies expect the transaction to close in late 2026 or early 2027.
Tempus Points to MRD Growth and Reimbursement Momentum Tempus said Personalis’ NeXT Personal offering has seen strong adoption, with quarter-over-quarter growth of 38%. The company said volumes could become “even more material and higher” as additional sales representatives are equipped to sell the offering and as more indications secure reimbursement.
Tempus AI Sold Off After a Beat—But the Rebound Case Is BuildingIn response to a question from Kallum Titchmarsh of Morgan Stanley, an executive identified as Eric said Tempus is “quickly gaining market adoption,” citing both overall growth in the MRD market and the performance of Personalis’ assay. He said Tempus expects to embed more of its technology into the MRD offering over time, including hospital connectivity, AI-enabled ordering tools and AI-derived insights.
Eric said Tempus has so far been selective in allowing its sales force to carry the MRD product, with roughly 10% of sales representatives currently involved. He said the company expects to expand that access as more indications receive reimbursement.
Why Tempus Says the Timing Is Right Asked by Kyle Mikson of Canaccord Genuity why Tempus is pursuing the acquisition now, Eric said the company had reviewed Personalis in 2023 but opted at that time for a commercial agreement because Personalis still faced several years of heavy investment. He said Personalis has since advanced the assay and is entering a phase in which coverage and reimbursement should improve the economics of the tests.
Eric said MRD assays can move from generating little or no revenue in certain uses to producing significant revenue after analytic validity, clinical validity, publication and MolDX approval requirements are met. He said Personalis is now entering that part of the cycle, and Tempus expects its financial profile to improve.
Jim Rogers, CFO and Treasurer of Tempus AI, said the company’s core business has “good tailwinds” from therapy selection volume growth and average selling price improvements. He said Tempus is generating incremental gross profit dollars and had already intended to reinvest a portion of that into the business, with MRD as a major investment area.
Data and Biopharma Opportunities Tempus said the Personalis portfolio also enhances its biopharma offering through profiling and immuno-oncology capabilities. The company highlighted the potential value of de-identified longitudinal MRD data, saying serial measurements can reveal disease dynamics, treatment response, resistance and recurrence, which may support biomarker discovery, patient selection and trial optimization.
Eric said the prior relationship between the companies gave Tempus broad clinical distribution rights, while Personalis retained its own biopharma business and data rights. After closing, he said Tempus expects to more tightly combine those capabilities, which he said could be “catalytic” to both companies’ pharma businesses.
Rogers added that Tempus already has a large biopharma data business and does sequencing for biopharma customers. He said integrating Personalis’ biopharma business with Tempus’ current offering could help expand overall relationships with biopharma clients.
Financial Targets Remain in Place Tempus said it will provide more detail on the transaction’s financial impact and outlook during its second-quarter earnings call on July 30. Despite the acquisition, the company said it intends to be adjusted EBITDA and free cash flow positive in 2027.
Asked about margins and reimbursement by Mark Massaro of BTIG, Eric said Tempus was not ready to provide extensive detail on Personalis’ business before a future update, but said Personalis is collecting clinical-side reimbursement dollars. He added that Tempus would not have agreed to the acquisition if it did not believe the margin profile would become “super healthy.”
Elizabeth Krutoholow, Tempus AI’s Vice President of Investor Relations, closed the call by thanking participants and said the company expects to speak with investors again on its July 30 second-quarter call.
About Tempus AI (NASDAQ:TEM)Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.
The company's core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Tempus AI Right Now?Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Investors looking for stocks in the Retail - Jewelry sector might want to consider either Signet (SIG) or Compagnie Financiere Richemont AG (CFRUY). But which of these two stocks presents investors with the better value opportunity right now?
Key Takeaways ALTO sees year-round E15 sales as a potential long-term catalyst for ethanol demand.Expanded E15 access could help absorb added low-carbon ethanol output and support industry margins.Nationwide E15 adoption, including California, could add roughly 1 billion gallons of ethanol demand. Alto Ingredients, Inc. (ALTO - Free Report) could benefit from expanding year-round E15 gasoline sales, which may become an important long-term demand catalyst for its ethanol business. While the company has been improving operations and benefiting from Section 45Z production tax credits, broader E15 adoption could strengthen domestic ethanol demand and provide a larger market for low-carbon renewable fuels. In its first-quarter 2026 earnings call, management highlighted California’s AB 30, which provides a pathway for year-round E15 sales, and noted growing momentum for similar legislation at the federal level.
Stronger demand is becoming increasingly important for ethanol producers. While production incentives encourage higher output, Alto Ingredients believes demand growth is necessary to prevent excess supply from weighing on industry margins. Management described expanded E15 access as an important complement to 45Z incentives by helping the market absorb additional low-carbon ethanol production over time while complementing demand from export markets.
The opportunity could become even more meaningful as Alto Ingredients continues improving production efficiency and operational performance. In its first-quarter earnings call, management cited industry estimates implying that nationwide year-round E15 adoption, including California, could add roughly 1 billion gallons of ethanol demand. While the pace of adoption remains dependent on policy implementation and market acceptance, broader E15 availability could represent a meaningful long-term growth catalyst for Alto Ingredients and the broader ethanol industry.
How ALTO's Ethanol Growth Story Compares With PeersGevo, Inc. (GEVO - Free Report) also sees expanding ethanol demand as an important long-term industry catalyst. In its first-quarter 2026 earnings call, Gevo said year-round E15 adoption could increase ethanol demand while highlighting growing export demand and the emergence of new low-carbon fuel markets. Gevo believes these demand drivers could support additional ethanol consumption and strengthen the growth opportunity for its low-carbon ethanol platform.
Green Plains Inc. (GPRE - Free Report) also views strong ethanol demand as an important long-term industry driver. In its first-quarter 2026 earnings call, Green Plains highlighted solid domestic and international demand, including healthy export markets, and said the structural backdrop for ethanol remains as positive as it has been in years. Green Plains believes sustained demand, combined with operational execution and its carbon strategy, supports the long-term cash-generation outlook and reinforces a constructive industry backdrop.
ALTO Stock Price Performance, Valuation & EstimatesShares of Alto Ingredients have surged 374.8% over the past year compared with the industry’s growth of 20.4%.
Image Source: Zacks Investment Research
From a valuation standpoint, ALTO trades at a forward price-to-sales ratio of 0.45, lower than the industry’s average of 3.3.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Alto Ingredients’ 2026 and 2027 earnings per share implies a year-over-year rise of 671.4% and 53.7%, respectively.
Image Source: Zacks Investment Research
Alto Ingredients currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Genomics is a broad and detailed study of genomes (an organism’s complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this area have heightened interest from pharmaceutical and biotechnology companies seeking deeper insight into disease biology and more effective therapeutic strategies.
It is important to distinguish between genetics and genomics. While genetics focuses on individual genes, genomics primarily aims to characterize all the genes of an organism. Genomics helps understand how genes operate within a living system and how they interact with one another and their environment.
Insights from genomic research are increasingly being used to evaluate how patients respond to specific drugs. These findings are also driving the development of precise, more targeted treatments, contributing to the advancement of personalized medicine. As demand for innovative therapies continues to grow, genomics is poised to play an increasingly central role in the future of healthcare, despite the complexity inherent in genome-scale research.
The expanding genomics landscape has also supported the growth of synthetic biology, which applies engineering principles to biology. This emerging field involves redesigning organisms for diverse applications, including drug discovery, disease detection, enzyme engineering, gene editing and foundational research.
The rapid progress in the novel space of genomics has been fueled by steep declines in the cost, time, and effort needed to sequence an individual’s genome. A major player in this field is Illumina (ILMN - Free Report) , a global leader in sequencing and array-based solutions for genetic and genomic analysis.
Diagnostic companies are using genomic sequencing data to identify genetic variations and connect them to known diseases. In contrast, other companies apply sequencing technologies to develop solutions across healthcare and other industries.
Another major advancement in the field is the emergence of genome-editing technologies, most notably CRISPR/Cas9. Companies specializing in gene editing, such as CRISPR Therapeutics AG (CRSP - Free Report) and Intellia Therapeutics, Inc. (NTLA - Free Report) , are exploring these tools to potentially treat or even cure diseases caused by genetic mutations. As the name implies, these technologies enable precise modifications to an organism’s DNA, allowing scientists to correct harmful defects at their source.
According to Fortune Business Insights, the global genomics market was valued at $34.23 billion in 2025 and is expected to expand from $38.24 billion in 2026 to $99.26 billion by 2034, reflecting a compound annual growth rate (CAGR) of 12.66% over the period.
Per a Grandview Research article, the global synthetic biology market size was valued at $18.9 billion in 2025 and is projected to reach $69.2 billion by 2033, at a CAGR of 17.7% from 2026 to 2033.
If you're looking to capitalize on this trend, our Genomics and Synthetic Biology screen makes it easy to identify high-potential stocks at any given time. At present, stocks such as Myriad Genetics (MYGN - Free Report) , Sana Biotechnology (SANA - Free Report) and Wave Life Sciences (WVE - Free Report) hold potential.
Explore 39 cutting-edge investment themes with Zacks Thematic Investing Screens and uncover your next big opportunity.
3 Genomics Stocks to ConsiderMyriad Genetics is a molecular diagnostics and precision medicine company focused on improving patient outcomes through advanced genetic testing. The company develops and commercializes innovative molecular diagnostic solutions that provide genetic insights to patients and healthcare providers. Its tests help evaluate disease risk, predict disease progression, and inform treatment decisions across multiple medical specialties. By enabling earlier detection, more personalized therapies, and better-informed clinical care, Myriad aims to enhance patient outcomes while helping reduce overall healthcare costs.
The company is experiencing strong momentum across its core cancer diagnostics business. Per management, its Cancer Care Continuum strategy is gaining traction, supported by a dedicated hereditary cancer sales force and targeted initiatives aimed at driving continued growth in germline testing. Management’s initiatives to strengthen the Prenatal Health business are expected to support stronger performance over the remainder of 2026. The limited launch of its Precise MRD test for breast cancer has generated encouraging early feedback. The company remains on track to launch additional tests in 2026, which it expects to become key growth drivers beginning in 2027.
Myriad Genetics also carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Sana Biotechnology is developing ex vivo and in vivo cell engineering platforms to revolutionize treatment of various diseases, such as type 1 diabetes (T1D), B-cell cancers and B-cell mediated autoimmune diseases. The company is advancing three lead therapeutic candidates built on its proprietary platform technologies. These include SC451, a HIP-edited product candidate for the treatment of type 1 diabetes for type 1 diabetes; SG293, an in vivo CAR T therapy for B-cell malignancies and B-cell-mediated autoimmune diseases; and SG227, an in vivo CAR T therapy for multiple myeloma. The company retains worldwide commercial rights to all three programs.
The company has collaborated with Mayo Clinic to advance development of SC451. Sana expects to file an investigational new drug application and begin a phase I study for SC451 as this year. Sana also plans to initially evaluate SG293 in non-Hodgkin lymphoma and report first-in-human data as early as this year. If successful, the company intends to expand SG293 into B-cell-mediated autoimmune diseases and advance SG227 into clinical studies for multiple myeloma.
SANA currently carries a Zacks Rank #2.
Wave Life Sciences is a clinical-stage biotechnology company harnessing the broad potential of ribonucleic acid (RNA) medicines (also known as oligonucleotides), or those targeting RNA, to transform human health. The company’s proprietary RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights with human genetics to deliver scientific breakthroughs that treat both rare and common disorders.
Its proprietary PRISM platform integrates multiple RNA-targeting approaches, including RNA interference (SpiNA) and RNA editing (AIMers), to create precision therapies. It boasts a diverse pipeline, including programs for obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006), PNPLA3 I148M-associated liver disease (WVE-008), Duchenne muscular dystrophy, Huntington's disease, and several preclinical candidates.
The company initiated the phase IIa multidose portion of the INLIGHT study, a placebo-controlled (3:1) study evaluating WVE-007 as monotherapy in individuals living with obesity with high BMI (35-50 kg/m2) and comorbidities. The company remains on track to launch additional phase II studies in the second half of 2026 evaluating WVE-007, both in combination with incretin therapies and as a maintenance treatment following incretin use.
Artificial intelligence infrastructure remains one of the market’s biggest investment themes, but it has also become one of its biggest sources of anxiety. Hyperscalers including Meta Platforms (NASDAQ:META | META Price Prediction), Microsoft (NASDAQ:MSFT), and Alphabet (NASDAQ:GOOG) are committing hundreds of billions of dollars annually to data centers, GPUs, and networking equipment, prompting concerns that debt and capital spending are getting ahead of future demand.
Yet not every financing announcement deserves the same reaction. Nebius Group (NASDAQ:NBIS) demonstrated that point today after unveiling a new funding agreement that appears to strengthen — not weaken — its long-term investment case.
The market agreed, as shares are gaining about 3% in midday trading today following the announcement it secured $775 million in its first secured debt financing, with proceeds earmarked for expanding its global AI infrastructure footprint.
Why This Debt Looks Different Debt has become a dirty word in AI investing, but context matters. Nebius’s latest financing differs from the massive borrowing programs undertaken by the largest cloud providers because of both its structure and purpose.
Unlike the convertible notes Nebius previously issued, this financing is secured by tangible assets, likely including data centers and related infrastructure. Asset-backed debt generally carries lower borrowing costs while avoiding the shareholder dilution that often accompanies convertible securities.
Just as important, lenders don’t extend secured financing without rigorous due diligence. The collateral must have measurable value, and the underlying business needs enough visibility to support repayment. In that sense, this financing serves as another vote of confidence in Nebius’s expanding infrastructure platform.
Let’s not overlook timing either. AI compute remains in short supply, allowing infrastructure providers to monetize new capacity quickly when backed by committed customers.
Fueling A Business Already Growing Rapidly Nebius isn’t borrowing simply to keep the lights on. The financing is designed to accelerate a business already benefiting from powerful industry tailwinds.
The company has landed major contracts with hyperscalers, including Meta, while maintaining a close relationship with Nvidia (NASDAQ:NVDA), whose GPUs remain the backbone of AI training and inference workloads. Those partnerships provide more revenue visibility than many early-stage infrastructure companies enjoy.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Nebius Group didn't make the cut. Grab the names FREE today.
That visibility matters because Nebius is pursuing an ambitious global expansion strategy centered on building GPU clusters and data centers capable of serving enterprise and hyperscale customers. Every new facility creates additional revenue-generating capacity.
Ironically, this is where Nebius differs from many concerns surrounding hyperscaler debt. Meta, Microsoft, and Alphabet will each spend between $100 billion and $200 billion this year on AI infrastructure from already enormous revenue bases. Nebius, by comparison, is much smaller, making percentage growth far higher while requiring far less absolute capital to expand.
The financing also diversifies Nebius’s capital structure. Moving beyond equity raises and convertible debt lowers its weighted average cost of capital while demonstrating that traditional lenders increasingly view its infrastructure as financeable assets rather than speculative projects.
The Risks Haven’t Disappeared Granted, investors shouldn’t mistake this announcement for a guarantee of success. Nebius still carries debt from earlier convertible offerings, while constructing AI data centers remains expensive and operationally challenging. Delays, cost overruns, or weaker-than-expected AI demand could reduce utilization rates and pressure returns on those investments. Competition from hyperscalers that eventually monetize excess computing capacity also remains a long-term consideration.
Those risks deserve monitoring, but today’s financing actually reduces one of the biggest uncertainties: whether Nebius could continue funding its aggressive expansion without leaning heavily on shareholder dilution.
Key Takeaway In short, Nebius’s $775 million secured financing is more than another capital raise. It represents validation from sophisticated lenders that the company’s infrastructure has meaningful collateral value and that its expansion plans are supported by visible demand. Combined with its relationships with Meta and Nvidia, the financing strengthens a growth narrative that was already gaining traction.
For investors looking beyond today’s 3% share-price gain, this announcement suggests Nebius is evolving from a promising AI upstart into a company capable of financing growth on increasingly favorable terms. In an industry where access to capital often determines who wins, that’s an encouraging milestone.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Nebius Group didn't make the cut. Grab the names FREE today.
Key Takeaways NBIS is expanding AI cloud capacity, products and partnerships while demand continues to exceed supply.C3.ai is restructuring operations, expanding AI adoption and improving enterprise product execution.NBIS reaffirmed its 2026 guidance, while AI faces revenue and profitability challenges Nebius Group N.V. (NBIS - Free Report) and C3.ai, Inc. (AI - Free Report) are capitalizing on the rapid adoption of AI, but they are pursuing distinct growth strategies to capture the expanding market opportunity. While Nebius is building an AI-native cloud infrastructure platform with a focus on hyperscale computing capacity, C3.ai is strengthening its enterprise AI software business through organizational changes, product enhancements and broader adoption of AI across its operations.
Both companies remain focused on expanding their AI capabilities and scaling their businesses to meet rising enterprise demand. However, their growth strategies, execution priorities and business models differ significantly, making the comparison important for investors seeking exposure to the AI sector.
Let’s evaluate their fundamentals, growth prospects, market challenges and valuations to determine which stock presents a stronger investment opportunity.
The Case for NBISNebius is rapidly expanding its AI-native hyperscaler platform by investing aggressively in capacity, products, customers and capital to strengthen its position in the AI infrastructure market. During the first quarter of 2026, the company increased its contracted power capacity from more than 2 gigawatts to more than 3.5 gigawatts and now expects to reach at least 4 gigawatts by the end of 2026. It also announced a new Pennsylvania facility that will support 1.2 gigawatts of power when fully operational. More than 75% of its contracted capacity is now owned, supporting its strategy of building a vertically integrated full-stack AI cloud platform. Management stated that the company is executing across four key pillars, capacity and scale, product and functionality, customers and demand, and capital, while remaining focused on disciplined execution across each area.
The company continues to expand beyond compute into cloud services that cover the complete AI lifecycle, including bare-metal infrastructure, multi-tenancy, inference and emerging agentic capabilities. NBIS strengthened its software and AI offerings through the acquisitions of Tavily, Eigen AI and Clarifai, which added experienced AI engineers and researchers while improving inference optimization, Token Factory capabilities and agentic search functionality. Management emphasized that these acquisitions accelerate product development, deepen customer engagement and strengthen Nebius' position as a full-stack AI cloud provider capable of serving a broader range of AI workloads.
Nebius is further reinforcing its AI leadership through an expanded partnership with NVIDIA Corporation (NVDA - Free Report) . The company achieved NVIDIA Exemplar Cloud status for GB300 training workloads, making it one of only a small number of cloud providers recognized across multiple GPU generations. Management noted that the partnership extends beyond hardware, providing differentiated GPU supply, closer collaboration on future NVIDIA platforms and deeper software integration for inference and agentic AI workloads. These initiatives strengthen Nebius' vertically integrated AI cloud platform while supporting future deployments built around NVIDIA's latest technologies.
Customer demand for Nebius' AI infrastructure remains exceptionally strong across AI-native companies, enterprises and software vendors, as well as industries including fintech, physical AI, life sciences, manufacturing, energy and pharmaceuticals. Management stated that several customers typically compete for every GPU brought online, while first-quarter pipeline generation increased 3.5 times sequentially. Demand continues to exceed available capacity, allowing the company to maintain strong pricing across GPU generations, extend contract durations, increase average contract values and receive growing customer prepayments to secure future AI capacity. The company also highlighted increasing momentum for its inference-focused Token Factory platform as AI adoption expands across enterprise and developer workloads.
Nebius delivered outstanding financial and operational performance during the first quarter, reflecting the strength of its expanding AI cloud business. Group revenue increased 684% year over year, while the Nebius AI business recorded 841% revenue growth and reached an annualized run-rate revenue of $1.9 billion. Group adjusted EBITDA margin improved to 32%, while the Nebius AI business achieved a 45% adjusted EBITDA margin. The balance sheet was further strengthened by a $4.3 billion convertible note offering, a $2 billion equity investment from NVIDIA and record customer prepayments, increasing cash and cash equivalents to $9.3 billion. Supported by this momentum, the company reaffirmed its 2026 guidance for annualized run-rate revenue of $7-$9 billion, group revenue of $3-$3.4 billion and an adjusted EBITDA margin of around 40%.
However, Nebius expects quarterly adjusted EBITDA margins to fluctuate during 2026 as it invests ahead of future capacity deployment. Management indicated that margins are likely to decline in the second quarter because infrastructure investments and operating expenses will be recognized before newly deployed capacity begins generating revenue. The company has also increased its 2026 capital expenditure guidance to $20-$25 billion from the previous $16-$20 billion range to support additional AI infrastructure planned for 2027. Nebius expects to utilize a combination of asset-backed financing, corporate debt, customer prepayments and other funding alternatives while maintaining a disciplined capital structure.
The Case for AIC3.ai is gaining from a broad restructuring initiative aimed at strengthening execution across the business. The company has reorganized its sales, products, services and federal operations under new leadership while introducing a strategic plan with clearly defined objectives. Product development has been consolidated under a single organization responsible for designing, developing, quality-assuring and delivering products, while the services organization has been redesigned with dedicated customer teams to support deployments through completion. Management highlighted that these changes are intended to improve customer satisfaction, enable more successful deployments and support the expansion of enterprise customer relationships.
The company is expanding its AI-first strategy by integrating agentic AI tools across the organization to improve productivity and execution. The company stated that its product teams are now using AI tools for programming activities, while legal, finance, sales and marketing functions have also adopted these agentic technologies. Sales teams are utilizing these tools to enhance market development, business development and customer penetration strategies. Management added that employees across every function are operating with an agentic AI-first mindset as the company focuses on execution and improving overall business performance.
C3.ai also highlighted several operational strengths, including a strong liquidity position and continued customer engagement. In fourth-quarter fiscal 2026, it signed nine initial production deployments, bringing the cumulative total to 417, with 251 remaining active through ongoing deployments, extensions or subscription and consumption agreements. Management also stated that cost reduction initiatives are progressing as planned and are expected to improve operating efficiency, free cash flow and support the company's long-term objectives.
However, C3.ai continues to face challenges from weak financial performance and declining revenue. Management acknowledged that the company's recent performance has been disappointing, describing sales execution as unacceptable and attributing the decline in revenue, remaining performance obligations and profitability primarily to poor sales discipline. The company reported quarterly revenue of $51.6 million, a non-GAAP operating loss of $54.4 million, a non-GAAP net loss of $48.8 million and negative free cash flow of $54.8 million.
C3.ai also indicated that uncertainty remains as it implements its new go-to-market strategy. On the last earnings call, management stated that the company has changed its sales organization and go-to-market approach, making it difficult to predict the future mix between software revenue, professional services, prioritized engineering services and demonstration licenses.
Share Performance for NBIS & AIIn the past six months, NBIS stock has surged 79.8% while AI lost 30.1%.
Image Source: Zacks Investment Research
Valuation for NBIS & AIIn terms of Price/Book, NBIS shares are trading at 6.21X, higher than AI’s 2X.
Image Source: Zacks Investment Research
How Do Estimates Compare for NBIS & AI?Over the past 60 days, analysts have marginally revised estimates upward for NBIS’ bottom line for the current year.
Image Source: Zacks Investment Research
For AI, estimates have been revised significantly upward over the past 60 days.
Image Source: Zacks Investment Research
NBIS or AI: Which Stock is the Better Investment?While NBIS sports a Zacks Rank #1 (Strong Buy) at present, C3.ai has a Zacks Rank #3 (Hold). Consequently, in terms of Zacks Rank, NBIS seems to be a better pick at the moment. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Redwire (RDW +4.08%) shares have surged twice over the past couple of years, only to fall off a cliff. It's a frustrating cycle given the company's intriguing growth potential as a supplier of components for space systems. Sometimes, volatility can create a life-changing buying opportunity, while other times, it's a signal to stay away.
It's crucial to understand what has held Redwire stock back in order to gauge what a $5,000 investment might look like in five years.
Strong growth potential, held back by two red flags Redwire supplies crucial components and systems to several high-growth industries, including satellites and drone systems, for both commercial and government applications.
The company reported first-quarter revenue of $97 million, up 57% year over year. Even more impressive was Redwire's 1.92 book-to-bill ratio, meaning that it booked far more new orders than it billed to customers. It points to the company's strong growth momentum. Management anticipates full-year sales of $450 million to $500 million, 49% growth from last year's $335.4 million at the high end of guidance.
Image source: Getty Images.
However, Redwire is deeply unprofitable. The business has burned roughly $165 million in free cash flow over the past four quarters, and net losses are even worse at $300 million. Redwire's share count has risen, roughly tripling since early 2025, and management announced a new offering in June to sell up to $500 million of new common shares on the market.
Suppose you invested $5,000 today Although Redwire's revenue could grow by 49% this year, it's asking a lot to assume the company sustains that growth rate. Instead, I'll assume revenue grows at an annualized rate of 25% over five years. Starting with last year's $335 million in sales, revenue would hit $1 billion in five years.
The stock also seems a bit expensive at 10 times its trailing-12-month earnings. For instance, Heico, an established aerospace components company, trades at 3.4 times sales. That company is growing at about 17% but is already profitable. I'll assume that Redwire's valuation ultimately settles at 5 times sales.
Today's Change
(
4.08
%) $
0.35
Current Price
$
8.80
Based on all that, Redwire would trade at a market value of approximately $5 billion in five years. That's a 150% return on the stock's current market cap of $2 billion, making Redwire a winner from here. Remember, that assumes a lot goes right over the next five years and doesn't factor in the recent $500 million offering or any additional shares added to the float during that period. The reality is that the returns could be far lower, even if the business does well.
Given the math above, I probably wouldn't chase Redwire at higher prices than where it is right now. That's at about $9 per share, far below its 52-week high. Above that, the risk becomes too high and the potential reward too low.
A downtrend has been apparent in D-Wave Quantum Inc. (QBTS - Free Report) lately with too much selling pressure. The stock has declined 32.2% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
Here's Why QBTS Could Experience a TurnaroundThe heavy selling of QBTS shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 29.83. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.
The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for QBTS has increased 2.3%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, QBTS currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Hut 8 Mining Corp (TSX:HUT, Unlisted (US):HUTMF) shares climbed nearly 12% on Monday after the company announced a second long-term lease agreement for its Beacon Point AI data center campus in Texas, fully commercializing the 1-gigawatt facility and increasing its contracted data center portfolio.
The company announced a 15-year lease agreement covering 352 megawatts (MW) of IT capacity with the same high-investment-grade tenant that signed the first phase lease at the campus. The agreement carries a base-term contract value of $9.8 billion and brings the tenant’s total contracted capacity at Beacon Point to 704 MW.
With the transaction, Hut 8’s total contracted AI data center capacity rises to 949 MW across its portfolio, supported by 1,330 MW of utility capacity. The company reported aggregate base-term contract value of $26.6 billion and average annual net operating income of more than $1.75 billion across its contracted AI data center assets.
The Beacon Point campus, located in Nueces County, Texas, is secured by a 1,000 MW utility interconnection agreement with AEP Texas. Hut 8 said the second lease fully commercializes the campus, with the full 1,000 MW capacity now contracted under two 15-year agreements.
The second phase lease will support the development of another 352 MW AI factory designed around Nvidia’s DSX reference architecture for large-scale AI infrastructure. Hut 8 expects initial Phase 2 data hall delivery in the second quarter of 2028.
The company expects the second lease to contribute $9.8 billion in cumulative net operating income over the base term, or approximately $655 million annually once stabilized. Including both phases, Hut 8 expects the full Beacon Point campus to generate $1.31 billion in average annual NOI.
Hut 8 noted that three five-year renewal options under each lease could increase potential campus-level contract value to $50.2 billion if fully exercised.
“The real test of our power-first approach is what our partners are willing to commit against it,” Asher Genoot, CEO of Hut 8, said.
“Our tenant at Beacon Point chose to double its footprint at the site, the strongest validation an asset can receive. We took this greenfield site from first lease to full commercialization in just months,” he said.
“That speaks to the quality of the sites we originate, the credibility of our delivery, and the long-term orientation of our partnerships. The opportunity ahead of us is to apply the same model across our development pipeline.”
The company also highlighted its “power-first” development approach, which involves securing energy capacity before building data center infrastructure. Hut 8 said the Beacon Point project was initially developed around speed-to-power opportunities before being converted into a fully contracted AI data center campus.
Construction activity is underway at the site, with long-lead equipment procured and initial energization still expected in the first quarter of 2027, according to the company.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores is a unique set of guidelines that rates stocks based on three popular investing types, and were developed as complementary indicators for the Zacks Rank. This combination helps investors choose securities with the highest chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.94% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
You want to make sure you're buying stocks with the highest likelihood of success, and to do that, you'll need to pick stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you like a stock that only has a #3 (Hold) rank, it should also have Scores of A or B to guarantee as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Brinker International (EAT - Free Report) Brinker International, Inc. is based in Dallas, TX. The company owns, operates, develops and franchises restaurants under the Chili’s Grill & Bar (Chili’s) and Maggiano’s Little Italy (Maggiano’s) brands. The company took over Chili’s, Inc., a Texas-based corporation, in September 1983. It completed the acquisition of Maggiano’s in August 1995.
EAT is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Additionally, the company could be a top pick for growth investors. EAT has a Growth Style Score of A, forecasting year-over-year earnings growth of 20.8% for the current fiscal year.
One analyst revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.01 to $10.75 per share. EAT boasts an average earnings surprise of +6.8%.
With a solid Zacks Rank and top-tier Growth and VGM Style Scores, EAT should be on investors' short list.
Analysts on Wall Street project that Tractor Supply (TSCO - Free Report) will announce quarterly earnings of $0.83 per share in its forthcoming report, representing an increase of 2.5% year over year. Revenues are projected to reach $4.63 billion, increasing 4.4% from the same quarter last year.
The current level reflects a downward revision of 1.8% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Tractor Supply metrics that are commonly tracked and projected by analysts on Wall Street.
The average prediction of analysts places 'Number of stores - Petsense' at 206 . The estimate is in contrast to the year-ago figure of 207 .
Analysts predict that the 'Number of stores' will reach 2,658 . The estimate is in contrast to the year-ago figure of 2,542 .
Based on the collective assessment of analysts, 'Number of stores - Tractor Supply' should arrive at 2,456 . Compared to the present estimate, the company reported 2,335 in the same quarter last year.
The consensus among analysts is that 'Sales per selling square foot' will reach $111.28 . The estimate is in contrast to the year-ago figure of $111.67 .
It is projected by analysts that the 'Total selling square footage' will reach 42 millions of square feet. Compared to the current estimate, the company reported 40 millions of square feet in the same quarter of the previous year.
The consensus estimate for 'New stores opened - Tractor Supply' stands at 18 . Compared to the current estimate, the company reported 24 in the same quarter of the previous year.
View all Key Company Metrics for Tractor Supply here>>>
Over the past month, shares of Tractor Supply have returned +0.9% versus the Zacks S&P 500 composite's +0.6% change. Currently, TSCO carries a Zacks Rank #4 (Sell), suggesting that it may underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Key Takeaways BigBear.ai enhanced Ask Sage and CargoSeer to broaden enterprise AI capabilities and customer reach.BBAI increased its backlog 14% as new contracts expanded across airports, defense and logistics.Technology products are becoming a larger revenue mix, supporting improved gross margin. BigBear.ai Holdings, Inc. (BBAI - Free Report) is accelerating product innovation to strengthen its competitive position in artificial intelligence and secure more enterprise customers. During its first-quarter 2026 earnings call, management highlighted that faster product development, combined with a customer-centric operating model, is helping the company expand its reach beyond traditional government contracts.
The company has realigned its sales, technology, delivery and customer success teams around the needs of operators in national security, and trade and travel. This restructuring is expected to speed up product development and deployment while enabling BigBear.ai to tailor solutions more effectively to customer requirements. The strategy also supports quicker decision-making and closer collaboration with clients.
Innovation across its recently acquired platforms is already showing results. CargoSeer introduced AI-powered invoice fraud detection for air cargo. At the same time, Ask Sage launched Version 2 featuring a simplified user interface, faster workflows and advanced tools such as Agent Builder and CodeCanvas. The company also expanded Ask Sage into commercial markets, allowing enterprises and international partners to access its secure generative AI platform.
These enhancements are supporting customer momentum. BigBear.ai secured new contracts across airports, shipbuilding, NASA and defense agencies, contributing to a 14% sequential increase in backlog to $281.9 million. Management also noted that technology products are becoming a larger share of revenues, helping to improve gross margin despite continued investments in research, development and sales.
While near-term profitability remains under pressure due to higher operating investments, BigBear.ai's faster innovation cycle and expanding AI portfolio position it well to attract more enterprise clients. Sustained execution and broader commercial adoption will be key to translating these product advancements into long-term revenue growth.
Can BigBear.ai Keep Pace With AI Industry Leaders?BigBear.ai faces intense competition from larger AI software providers like Palantir Technologies (PLTR - Free Report) and C3.ai (AI - Free Report) , both of which are expanding their enterprise AI offerings. Palantir continues to strengthen its commercial business through the Artificial Intelligence Platform, helping enterprises deploy generative AI applications at scale. Its strong customer adoption, growing commercial revenues and deep integration capabilities make Palantir a formidable rival in winning large enterprise contracts.
C3.ai is also focused on accelerating enterprise AI adoption through industry-specific applications across manufacturing, energy, financial services and defense. The company continues to enhance its generative AI capabilities while expanding partnerships with major cloud providers to broaden customer reach.
Unlike these broader AI platforms, BigBear.ai differentiates itself through mission-ready AI solutions tailored for national security, border protection, logistics and critical infrastructure. Its recent enhancements to Ask Sage and CargoSeer, along with a faster product development cycle, could help the company capture niche enterprise opportunities. However, sustained innovation and successful commercialization will be essential for BigBear.ai to compete effectively against larger and better-capitalized AI rivals.
BBAI’s Price Performance, Valuation & EPS Estimate TrendShares of BBAI have declined 50.3% over the past six months, underperforming the Zacks Computers - IT Services industry, as shown below.
BBAI’s 6-Month Price Performance
Image Source: Zacks Investment Research
BBAI stock is currently trading at a discount compared with the industry peers, with a forward 12-month price-to-sales (P/S) ratio of 8.71, as evidenced by the chart below.
P/S Ratio (F12M)
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BBAI’s 2026 loss per share has remained stable in the past 60 days, as shown below. The estimated figure indicates a narrower loss from the year-ago loss of 82 cents per share.
EPS Trend of BBAI
Image Source: Zacks Investment Research
BBAI’s Zacks RankBigBear.ai currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Bitmine hält 4,8 % des gesamten ETH-Umlaufs von 120,7 Millionen
Bitmine hat in nur 12 Monaten bereits 96 % des Weges zur „Alchemie der 5 %" zurückgelegt
Bitmine hat in der vergangenen Woche 5,5 Millionen Stammaktien zurückgekauft, die im Rahmen des zuvor angekündigten Aktienrückkaufprogramms in Höhe von 4 Milliarden US-Dollar genehmigt worden waren.
Bitmine wurde am 26. Juni 2026 in den Russell 1000 Large-Cap-Index aufgenommen
Die Vorzugsaktien der Serie A von Bitmine werden an der NYSE unter dem Symbol BMNP gehandelt
Bitmine verfügt über 4.917.189 gestakte ETH, was bei einem Kurs von 1.879 US-Dollar pro ETH einem Wert von 9,2 Milliarden US-Dollar entspricht. MAVAN (Made in America VAlidator Network) ist eine führende Ethereum-Staking-Plattform für BMNR und institutionelle Anleger
Bitmine hält Anteile an Eightco im Wert von 58 Millionen US-Dollar (NASDAQ: ORBS), das mittlerweile zu den wenigen börsennotierten Aktien weltweit zählt, die Anlegern ein indirektes Engagement in OpenAI ermöglichen
Die Kryptowährungsbestände von Bitmine sowie die gesamten Barmittel und marktfähigen Wertpapiere und die „Moonshots" belaufen sich auf insgesamt 11,5 Milliarden US-Dollar, darunter 5,78 Millionen ETH-Token, Barmittel und marktfähige Wertpapiere in Höhe von 385 Millionen US-Dollar sowie sonstige Kryptowährungsbestände.
Bitmine wird weiterhin von einer Gruppe führender institutioneller Investoren unterstützt, darunter Cathie Wood von ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital und der Privatinvestor Thomas „Tom" Lee, um das Ziel von Bitmine zu unterstützen, 5 % der ETH zu erwerben
, /PRNewswire/ -- (NYSE: BMNR) Bitmine Immersion Technologies, Inc. („Bitmine" oder das „Unternehmen"), ein auf Bitcoin und das Ethereum-Netzwerk spezialisiertes Unternehmen, dessen Schwerpunkt auf dem Aufbau von Kryptowährungsbeständen für langfristige Investitionen liegt, gab heute bekannt, dass sich die Gesamtwert der Bitmine-Krypto-Bestände sowie der Barmittel und marktfähigen Wertpapiere und der „Moonshots"-Bestände auf insgesamt 11,5 Milliarden US-Dollar belaufen.
Bitmine Weekly Update
STAKING: BMNR now staking over 4.9 million ETH as of July 19, 2026
ALCHEMY OF 5%: BMNR ranked #187 by 5D avg daily $ volume Stand 19. Juli 2026, 20:30 Uhr ET, setzen sich die Kryptowährungsbestände des Unternehmens aus 5.777.468 ETH zu einem Kurs von 1.879 US-Dollar pro ETH zusammen (laut Coinbase, NASDAQ: COIN), 207 Bitcoin (BTC), eine Beteiligung in Höhe von 180 Millionen US-Dollar an Beast Industries, eine Beteiligung in Höhe von 58 Millionen US-Dollar an Eightco Holdings (NASDAQ: ORBS) („Moonshots") sowie Barmittel und marktfähige Wertpapiere in Höhe von insgesamt 385 Millionen US-Dollar. Die ETH-Bestände von Bitmine machen 4,8 % des ETH-Gesamtbestands (von 120,7 Millionen ETH) aus.
„Bitmine hat in der vergangenen Woche rund 5,5 Millionen Stammaktien zu einem Durchschnittspreis von 15,6156 US-Dollar zurückgekauft. Wir betrachten den Rückkauf unserer Stammaktien als wertsteigernd für die Aktionäre", erklärte Thomas „Tom" Lee, Chairman von Bitmine.
Bitmine hat den Rückkauf von 5,5 Millionen Stammaktien im Rahmen des zuvor genehmigten Aktienrückkaufprogramms in Höhe von 4 Milliarden US-Dollar durchgeführt.
„In der vergangenen Woche haben wir 7.430 ETH erworben. Das geringere Kaufvolumen spiegelt wider, dass Bitmine 5,5 Millionen Stammaktien zurückgekauft hat. Bitmine hat seit Einführung der ETH-Treasury-Strategie am 30. Juni 2025 jede Woche ETH gekauft", erklärte Lee.
Am 16. Juli 2026 veröffentlichte Bitmine die neueste Botschaft des Vorstandsvorsitzenden (Link hier:) für Juli 2026. Der Titel der Botschaft lautet: „ETH is the cure for the Uncanny Valley of Wealth."
Anfang 2026 brachte Bitmine MAVAN (das „Made in American VAlidator Network") auf den Markt, eine Staking-Plattform für institutionelle Anleger. Während MAVAN ursprünglich entwickelt wurde, um die eigene Ethereum-Treasury von Bitmine zu unterstützen, beabsichtigt MAVAN, sein Angebot auszuweiten, um institutionelle Anleger, Verwahrstellen und Ökosystempartner zu bedienen, die eine erstklassige Staking-Infrastruktur suchen. Ein Teil der ETH von Bitmine ist bereits auf der MAVAN-Plattform gestakt.
Stand 19. Juli 2026 beläuft sich die Gesamtmenge der bei Bitmine gestakten ETH auf 4.917.189 (9,2 Milliarden US-Dollar bei einem Kurs von 1.879 US-Dollar pro ETH). „Bitmine hat mehr ETH gestakt als jede andere Organisation weltweit. Im großen Maßstab (wenn die ETH von Bitmine vollständig von MAVAN und seinen Staking-Partnern gestaked wird) beläuft sich die prognostizierte ETH-Staking-Prämie auf annualisierter Basis auf 290 Millionen US-Dollar (unter Zugrundelegung einer 7-Tage-BMNR-Rendite von 2,67 %)", erklärte Lee.
„Die annualisierten Staking-Erträge werden nun auf 247 Millionen Dollar geschätzt. Und diese 4,9 Millionen ETH entsprechen 85 % der 5,78 Millionen ETH, die Bitmine hält. Die eigenen Staking-Aktivitäten von Bitmine erzielten eine 7-Tage-Rendite von 2,67 % (annualisiert)", fuhr Lee fort.
Die Kryptowährungsbestände von Bitmine sind die größte Ethereum-Kasse und die zweitgrößte Kasse weltweit, hinter Strategy Inc., das Berichten zufolge 843.775 BTC im Wert von etwa 55 Milliarden US-Dollar besitzt. Bitmine bleibt die weltweit größte ETH-Treasury.
Bitmine ist eine der am häufigsten gehandelten Aktien in den USA. Nach Angaben von Fundstrat verzeichnete die Aktie ein durchschnittliches tägliches Handelsvolumen von 579 Millionen US-Dollar (5-Tage-Durchschnitt, Stand: 17. Juli 2026) und belegt damit Platz 187 in den USA – hinter Airbnb (Platz 186) und vor Fastenal (Platz 188) unter 5.704 in den USA notierten Aktien (statista.com und Fundstrat-Research).
Die Geschäftsführung von Bitmine ist der Ansicht, dass der GENIUS Act und das Project Crypto der Securities and Exchange Commission (SEC) für die Finanzdienstleistungen im Jahr 2025 ebenso wegweisend sind wie die Maßnahmen der USA vom 15. August 1971, mit denen vor 54 Jahren das Bretton-Woods-System und die Bindung des US-Dollars an den Goldstandard beendet wurden. Dieses Ereignis aus dem Jahr 1971 war der Auslöser für die Modernisierung der Wall Street und führte zur Entstehung der legendären Wall-Street-Giganten sowie der heutigen Finanz- und Zahlungsinfrastruktur. Diese erwiesen sich als bessere Investitionen als Gold.
Die Nachricht des Chairman von Bitmine finden Sie hier:
https://www.Bitminetech.io/chairmans-message
Die Präsentation der Ergebnisse für das gesamte Geschäftsjahr 2025 sowie die Unternehmenspräsentation finden Sie hier: https://Bitminetech.io/investor-relations/
Wenn Sie an aktuellen Informationen interessiert sind, melden Sie sich bitte hier an: https://Bitminetech.io/contact-us/
Informationen zu Bitmine
Bitmine (NYSE: BMNR) ist ein Bitcoin-Miner mit Aktivitäten in den USA. Das Unternehmen setzt sein überschüssiges Kapital ein, um das weltweit führende Ethereum-Treasury-Unternehmen zu werden, und verfolgt eine innovative Strategie für digitale Vermögenswerte für institutionelle Investoren und Teilnehmer an den öffentlichen Kapitalmärkten. Geleitet von seiner Philosophie der „Alchemy of 5 %" setzt das Unternehmen auf ETH als primären Treasury-Reservewert und nutzt dabei protokollnative Aktivitäten, darunter Staking und dezentrale Finanzmechanismen. Das Unternehmen führte im Jahr 2026 MAVAN (Made in America VAlidator Network) ein, eine spezielle Staking-Infrastruktur für Bitmine-Vermögenswerte.
Weitere Informationen finden Sie auf X:
https://x.com/bitmnr
https://x.com/fundstrat
Zukunftsgerichtete Aussagen
Diese Pressemitteilung enthält Aussagen, die „zukunftsgerichtete Aussagen" im Sinne des Private Securities Litigation Reform Act von 1995 darstellen. Die Aussagen in dieser Pressemitteilung, die nicht rein historischer Natur sind, sind zukunftsgerichtete Aussagen, die Risiken und Unsicherheiten beinhalten. Diese zukunftsgerichteten Aussagen sind an Begriffen wie „erwartet", „plant", „prognostiziert", „beabsichtigt", „glaubt", „geht davon aus", „schätzt" und ähnlichen Formulierungen zu erkennen. Dieses Dokument enthält insbesondere zukunftsgerichtete Aussagen zu folgenden Punkten: (i) die Ziele des Unternehmens hinsichtlich des Erwerbs von ETH, einschließlich der Initiative „Alchemy der 5 %" und der Aussage, dass Bitmine dieses Ziel bereits zu 96 % erreicht habe; (ii) die Strategie des Unternehmens zum Aufbau digitaler Vermögenswerte sowie seine Staking-Aktivitäten, einschließlich der Aussage, dass Bitmine über 4.917.189 gestakte ETH im Wert von 9,2 Milliarden US-Dollar verfügt, prognostizierte annualisierte ETH-Staking-Erträge von etwa 290 Millionen US-Dollar (sofern die ETH von Bitmine vollständig durch MAVAN und dessen Staking-Partner gestakt wird) sowie derzeit prognostizierte annualisierte Staking-Erlöse von etwa 247 Millionen US-Dollar; (iii) die geplante Expansion von MAVAN zur Betreuung institutioneller Anleger, Verwahrstellen und Ökosystempartner, die eine erstklassige Staking-Infrastruktur suchen; (iv) das anhaltende Engagement des Unternehmens, im Rahmen seiner ETH-Treasury-Strategie wöchentlich ETH zu erwerben; (v) die Überzeugung des Managements, dass der GENIUS Act und das SEC-Projekt „Crypto" für die Finanzdienstleistungen ebenso transformativ sind wie die Maßnahmen der USA vom 15. August 1971, mit denen das Bretton-Woods-System und der Goldstandard des US-Dollars beendet wurden; (vi) die Erwartungen hinsichtlich des Aktienrückkaufprogramms in Höhe von 4 Milliarden US-Dollar und dessen wertsteigernde Wirkung für die Aktionäre; (vii) Aussagen darüber, dass die Investition des Unternehmens in Eightco Holdings ein indirektes Engagement bei OpenAI darstellt; sowie (viii) das künftige Wachstum und die Weiterentwicklung der Ethereum-Treasury-Strategie des Unternehmens. Bei der Bewertung dieser zukunftsgerichteten Aussagen sollten Sie verschiedene Faktoren berücksichtigen, darunter: die Fähigkeit von Bitmine, mit neuen Technologien und sich wandelnden Marktanforderungen Schritt zu halten; die Fähigkeit von Bitmine, sein laufendes Geschäft, die Ethereum-Treasury-Aktivitäten, Aktienrückkaufmaßnahmen sowie geplante zukünftige Geschäftsvorhaben zu finanzieren; das Wettbewerbsumfeld, in dem Bitmine tätig ist; Marktbedingungen, die den Handelskurs der Stammaktien und der Vorzugsaktien der Serie A des Unternehmens beeinflussen; regulatorische Entwicklungen im Bereich digitaler Vermögenswerte, einschließlich der endgültigen Verabschiedung und Umsetzung des GENIUS Act sowie anderer anhängiger Gesetzgebungsvorhaben und Initiativen der SEC; die Volatilität und Unvorhersehbarkeit der Preise digitaler Vermögenswerte; die Leistung, Zuverlässigkeit und Sicherheit der Staking-Aktivitäten des Unternehmens; Risiken im Zusammenhang mit KI-Systemen und deren Auswirkungen auf die Kryptowährungsmärkte; sowie der zukünftige Wert von Bitcoin und Ethereum. Die tatsächlichen künftigen Entwicklungen und Ergebnisse können wesentlich von den in zukunftsgerichteten Aussagen enthaltenen Angaben abweichen. Zukunftsgerichtete Aussagen unterliegen zahlreichen Bedingungen, von denen viele außerhalb der Kontrolle von Bitmine liegen, einschließlich derjenigen, die im Abschnitt „Risikofaktoren" des Formulars 10-K von Bitmine aufgeführt sind, das am 21. November 2025 bei der SEC eingereicht wurde, sowie allen anderen bei der SEC eingereichten Unterlagen, die von Zeit zu Zeit geändert oder aktualisiert werden. Kopien der von Bitmine bei der SEC eingereichten Unterlagen sind auf der Website der SEC, www.sec.gov, verfügbar. Bitmine übernimmt keine Verpflichtung, diese Aussagen bei Überarbeitungen oder Änderungen nach dem Datum dieser Mitteilung zu aktualisieren, es sei denn, dies ist gesetzlich vorgeschrieben.
IREN Ltd (IREN) shares are ripping higher this morning following a significant operational update that alleviate capital expenditure concerns and boosts the firm’s long-term financial outlook.
The Australian vertically integrated data center and artificial intelligence (AI) cloud company says it has signed $2.8 billion in total contract value across new multi-year cloud services contracts.
Despite today’s surge, IREN stock continues to trade roughly 40% below its recent high.
Investors are cheering IREN shares today primarily because the said agreements expand the firm’s footprint across both bare-metal and managed cloud services.
Notably, its active customer roster now boasts key hyperscalers, frontier artificial intelligence labs, and enterprise clients, including Microsoft, Nvidia, Figure AI, Perplexity, and Together AI.
This signals durable, “high‑margin” recurring revenue – reinforcing visibility into IREN’s scaling trajectory and materially strengthening confidence in its multi‑year growth runway.
From a technical perspective, IREN now looks headed to challenge its 20-day MA, with a decisive break above the $43 level expected to boost upward momentum in the near-term.
IREN stock is extending gains on July 20th also because these new signings made management lift its AI annual recurring revenue (ARR) guidance.
The company now expects its ARR to surpass $4 billion this year, up from the previously estimated $3.7 billion.
Crucially, management noted that about 85% of this new $4 billion+ target is already locked in under contract.
For a neocloud operator scaling physical data center infrastructure, the burden of purchasing high-end GPUs is typically the heaviest strain on cash flow.
A major catalyst for rising institutional interest today is that these recent contracts include customer prepayments covering roughly 45% of the associated GPU capital expenditure.
This lowers IREN’s net external funding requirements and minimizes the threat of near-term equity dilution.
All in all, the announcement brings much-needed reprieve to IREN shares that have otherwise been under immense pressure amidst broader AI infrastructure valuation fatigue in recent months.
Today’s update effectively proves that demand for data center capacity remains robust and – more importantly – validates IREN’s ability to convert its huge 5 GW secured power pipeline into highly lucrative, contracted, and partially upfront-funded recurring revenue.
The renewed momentum also helps reset sentiment around IREN’s execution cadence, positioning the stock to re‑rate as investors increasingly reward operators with contracted scale, upfront capital support, and demonstrable leverage on their power‑rich infrastructure portfolios.
Investors could also take heart in the fact that Wall Street firms remain super bullish on IREN for the remainder of 2026.
While the consensus rating on it sits at Moderate Buy, the mean price target of nearly $81 signals the stock could more than double from here over the next 12 months.
Shares of the artificial intelligence (AI) cloud provider Iren Limited (IREN +20.14%) jumped nearly 20% Monday morning after a big revision to its 2026 revenue target. The announcement showed that AI infrastructure investments continue to grow, despite fears that a bubble is forming.
Iren stock eased off its early jump, but remained up by 16.7% as of 11:45 a.m. ET.
Image source: The Motley Fool.
AI developers keep spending Tech stocks have been volatile recently as investors balance the massive spending to build out compute capacity for AI models with fears of a bubble if companies do not receive proper returns on those investments.
Iren announced today that it has continued to sign contracts to lease out its data center capacity. It says it has new long-term cloud service agreements that allow it to raise its year-end annual revenue run rate to over $4 billion. That's up from $3.7 billion and assumes its planned cloud capacity increases are completed this year.
Today's Change
(
20.14
%) $
6.77
Current Price
$
40.39
As companies need more computing resources for AI training and inference, they are seeking contracts with companies like Iren. Its customers include tech giants such as Nvidia and Microsoft, as well as private cloud computing companies like Perplexity and Fluidstack.
The biggest reason investors jumped in today may be that the company noted that "contracted pricing continues to strengthen."
That's a good sign that companies are confident that they will see proper returns on these investments, and that demand for Iren's capacity remains strong.
Howard Smith has positions in Microsoft and Nvidia. The Motley Fool has positions in and recommends Microsoft and Nvidia. The Motley Fool has a disclosure policy.
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP highlights the contrast between Futu Holdings Limited's (NASDAQ: FUTU) public assurances and what allegedly happened behind the scenes. Investors who purchased FUTU securities between May 24, 2023 and May 27, 2026 and suffered losses may be entitled to compensation. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.
FUTU shares lost $34.10 per share on May 22, 2026, a 27.5% single-session decline, after regulators proposed penalties of approximately USD 271 million. The lead plaintiff deadline is August 25, 2026.
The Promise: Compliance Through Rectification
Beginning in 2023, Futu repeatedly told the investing public that it was cooperating with the China Securities Regulatory Commission. In its FY2023 annual report filed with the SEC, the Company stated it had "taken and may continue to take rectification measures on our business based on the requirements from the CSRC." The Company pointed to the removal of its Futubull app from mainland Chinese app stores as evidence of its compliance efforts. Across multiple SEC filings through 2025, Futu used nearly identical language, creating the impression that regulatory risk was being actively managed and reduced.
The Reality: Continued Unlicensed Operations
The CSRC's May 2026 Notification Letter told a different story, the lawsuit contends. According to the action, Futu entities in mainland China and Hong Kong had continued to conduct securities business, public fund sales, and futures business without obtaining the requisite licenses or approval. The rectification measures Futu publicly touted allegedly did not stop the unlicensed activity that regulators had flagged years earlier.
The Numbers: Promised vs. Actual
The Promise: "We have taken rectification measures … based on the requirements from the CSRC" (FY2023 and FY2024 20-F filings)The Reality: CSRC proposed confiscation of RMB 470 million in illegal gains, confirming alleged continued unlicensed operationsThe Promise: Risk factor language framing penalties as speculative possibilities that "could" or "may" occurThe Reality: RMB 1.85 billion aggregate penalty proposed, approximately USD 271 millionThe Promise: Quarterly earnings releases touting paying client growth from 1.5 million to over 3.3 million (funded accounts) and client assets surging past HK$900 billionThe Reality: Revenue generated from mainland Chinese investors was allegedly derived from unlicensed activity, rendering reported financial growth figures materially misleading Speak with an attorney about whether you can recover damages or call (212) 363-7500.
What the Lawsuit Alleges About the Gap
The complaint asserts that Futu's public statements created a false narrative of regulatory cooperation while the Company continued the precise conduct the CSRC had warned against. Quarter after quarter, Futu reported surging client numbers, expanding trading volumes, and rising revenues without disclosing that a material portion of this growth allegedly stemmed from business conducted in violation of Chinese securities regulations.
The gap between what investors were told and what was allegedly occurring is at the core of this securities action. When the CSRC finally proposed its penalty in May 2026, investors absorbed losses of more than $34 per share in a single trading session, followed by an additional $5.31 per share decline days later when Q1 2026 earnings reflected the penalty's financial impact.
"Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The contrast between Futu's repeated assurances of regulatory cooperation and the scale of the proposed penalty raises serious questions about the adequacy of the Company's disclosures throughout the Class Period." -- Joseph E. Levi, Esq.
Join the FUTU recovery action to pursue your per-share losses or contact Joseph E. Levi, Esq. at (212) 363-7500.
ABOUT LEVI & KORSINSKY, LLP — Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report. Investors who suffered losses have until August 25, 2026 to seek appointment as lead plaintiff. Attorney Advertising. Prior results do not guarantee similar outcomes.
Frequently Asked Questions About the FUTU Lawsuit
Q: What specific misstatements does the FUTU lawsuit allege? A: The complaint alleges Futu Holdings made materially false or misleading statements regarding its compliance with CSRC regulatory requirements and the adequacy of its rectification measures during the Class Period. When the true state of affairs was revealed through the CSRC's proposed RMB 1.85 billion penalty, the stock price declined sharply.
Q: How much did FUTU stock drop? A: Shares fell approximately 27.5%, a decline of $34.10 per share, after the Company disclosed receipt of a CSRC Notification Letter proposing penalties of approximately USD 271 million. Shares dropped an additional 4.8% ($5.31 per share) days later when Q1 2026 earnings reflected the penalty.
Q: What if I already sold my FUTU shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the Class Period and sold at a loss may still participate.
Q: What do FUTU investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.
Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.
Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.
Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.
Q: When did Futu Holdings allegedly mislead investors? A: The Class Period runs from May 24, 2023 to May 27, 2026. The alleged fraud was revealed through corrective disclosures on May 22, 2026 and May 28, 2026, causing significant stock declines on both dates.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004 [email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171